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The overall goal of this dissertation is to describe the development of a dynamic diffuse optical 
tomographic (DDOT) imaging system for the diagnosis and monitoring of peripheral arterial 
disease (PAD) within the lower extremities. PAD affects 8-12 million individuals in the United 
States and is associated with significant morbidity and mortality. Early detection and monitoring 
of disease progression is crucial, but remains difficult.  This is especially true for diabetic 
patients, as roughly 30 percent of all diabetic patients over the age of 50 are diagnosed with PAD. 
Diabetic patients have calcified arteries, which renders them incompressible.  This falsely 
elevates blood pressure readings and causes false negative readings using traditional diagnostic 
techniques.  DDOT offers an attractive opportunity to overcome current shortcomings in 
assessing PAD. This technology uses harmless near-infrared light to create three-dimensional, 
time-dependent images of biological tissues. Using DDOT to measure blood-perfusion in the 
foot should help diagnose and monitor the PAD. To test this hypothesis, I adapted an existing 
optical tomographic imaging system for the particular application of vascular imaging in the foot. 
In particular I design and tested various measuring probes that can accommodate different foot 
sizes and shapes. The result was a patient friendly interface that can be employed in a clinical 
setting.  Using this modified DDOT imager, which we called vascular optical tomographic 
imaging (VOTI) system, I conducted a 40-subject pilot study to quantify its ability to diagnose 
!
!
PAD.  The subjects were recruited into three cohorts, non-diabetic PAD patients (N=10), PAD 
Patients (N=10) and healthy volunteers (N=20). With this data in hand, I performed a 
comprehensive data analysis, in which I found imaging features that led to a good separation 
between the healthy and affected cohorts. In particular I demonstrated that statistically 
significant difference exist between the amount of blood pooling in the leg during a 1-minute, 
60mmHg thigh cuff occlusion within healthy subjects and both affected cohorts (P=0.006, 
P=0.006). In addition, using receiver operating characteristic (ROC) curve analysis, I identified 
that the new VOTI system could diagnose PAD with a sensitivity and specificity of over 80%, 
even within the diabetic patients.  This imaging modality was also capable of identifying the 
severity of the disease with similar accuracy to the existing diagnostic methods while not being 
inhibited by arterial calcifications.  Furthermore, the VOTI system provided spatial information, 
helping identify which regions of the foot suffered from mal-perfusion.  When combined with 
angiosome theory, the spatial information could help physicians in deciding how to intervene in 
PAD patients. 
After completing this first clinical study, I developed a dedicated VOTI system by 
entirely redesigning the hard and software. This new system has many novelties over its 
predecessor. First it employs a contact-free patient interface that allows to imaging patients with 
ulcerations. The illumination fibers used do not need to make physical contact with the patient. 
Second, instead of using individual silicon photodiodes as detectors, a highly sensitive CCD 
camera is use to detect transmitted light intensity. The system has two wavelengths of light (660 
and 860 nm), which can be illuminated at up to 20 different positions along the surface of the 
foot. The system is built for dynamic imaging and is capable of imaging at a multispectral-
volumetric frame rate speeds of 1 Hz. This set-up allows us to create three-dimensional images 
!
!
of large portions of the foot. This imaging system was tested on phantom studies and healthy 
volunteers and was shown to be able to image blood flow dynamics within a three-dimensional 
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1.1 Overall goals and thesis outline 
The overall goal of the dissertation is to develop a diffuse optical tomographic imaging system 
for the diagnosis and monitor peripheral arterial disease (PAD) within the lower extremities. 
PAD is the narrowing of the functional area of the arteries due to plaque accumulation and in the 
vascular walls (atherosclerosis).  This prevents blood from reaching vital organs, as well as the 
extremities.  If left untreated, the disease eventually leads to formation of foot wounds or 
ulcerations, which can subsequently lead to infection, tissue loss (gangrene), and ultimately 
amputation.  
Currently various tests and technologies are used to diagnose and assess PAD, as well as 
identify locations of vascular occlusions throughout the leg.  However, these techniques do not 
function properly within diabetic patients, patients with renal insufficiency and many elderly 
patients.  This patient subset often has calcified (incompressible) arteries, which introduces error 
in the blood pressure and plethysmography based diagnostic techniques.  Furthermore, the 
current methods do not give information about the overall perfusion of the foot and cannot be 
used to monitor perfusion after a vascular intervention, such as angioplasty or by-pass surgery.   
Vascular optical tomography imaging (VOTI) offers a solution to these shortcomings with its 
ability to non-invasively image perfusion in the foot without ionizing radiation or contrast 
injection.  To test this hypothesis, I pursued the following three specific aims: 
(1) Specific Aim 1: adapted an existing VOTI system for cross-sectional imaging of blood 
perfusion in feet.  







clinical pilot study with 10 non-diabetic PAD, 10 diabetic PAD patients, and 20 healthy 
volunteers. 
(3) Specific Aim 3: Based on results in specific aims 1 and 2, I designed and built a new-
dedicated foot imaging system. This system has a contact-free patient interface and 3D 
imaging capabilities. 
Unlike current techniques, the new technology is able to image independently of arterial 
compressibility, and does not require contrast agents or the use of ionizing radiation. In addition, 
it allows physicians to visualize the perfusion response of the foot, giving spatial information on 
where blood is most deficient.  
The dissertation is organized as follows: In Chapter 1, I introduce peripheral arterial 
disease its prevalence, symptoms and current diagnostic methods. I will also introduce 
fundamental optical interactions with tissues, including absorption, and scattering, then go on to 
outline the fundaments of diffuse optical tomography, including imaging modes, and hardware 
choices. 
In Chapter 2, I discuss the design of a new measuring probe/patient interface that I used 
to modify an existing VOTI system for foot imaging.  I outline the details of a 40-subect 
diagnostic clinical study including the study population, cohort selection, imaging protocol, data 
pre/post-processing and image reconstruction algorithms.  Furthermore, I describe the methods 
for handling the large data sets as well as feature extraction and analysis techniques.  I explain 
the statistical analysis for evaluating VOTI’s ability to diagnose, assess severity as well as 
localize PAD in the foot.  
In Chapter 3, I discuss the design and fabrication of a new dedicated VOTI system for 







for faster setup times and imaging of patients with ulcerations and three-dimensional imaging 
capabilities.  The individual components of the system are explained in great detail as well as 
how they interface with each other. The user/patient interfaces are also outlined.  I describe the 
system specifications and how I derived them using phantom experiments. The chapter 
concludes with the presentation of a case study involving healthy volunteer during a thigh cuff 
stimulus. 
 
1.2 Peripheral arterial disease 
1.2.1 Background 
Peripheral arterial disease (PAD) is the narrowing of the functional area of the arteries due to 
plaque accumulation and in the vascular walls (atherosclerosis). PAD typically manifests itself as 
claudication, which is defined as a cramping leg pain with ambulation to a set distance. As the 
disease progresses, this distance becomes progressively shorter, and in later stages the pain 
becomes severe and present even at rest.  Untreated, the disease eventually leads to formation of 
foot wounds or ulcerations, which can subsequently lead to infection of the wound and tissue 
loss (gangrene), and ultimately amputation. [1-3] 
PAD affects approximately 12 million individuals in the United States and is associated 
with significant morbidity and mortality [2]. Every year, PAD is responsible for over 2,750,000 
office visits, 10% of which result in hospital admissions. Approximately 45,000 PAD patients 
die from this disease annually [3]. Furthermore, patients with PAD have an increased risk of 
stroke and myocardial infarction, and show a two-fold increase in the risk of death from 







hyperlipidemia, hypercholesterolemia, and diabetes.  Currently 85% of lower leg amputations 
occur within diabetic patients. When linked with diabetes. PAD results in over 71,000 
amputations annually [4-7].  
In addition to lifestyle changes such as smoking cessation and exercise programs, 
antiplatelet drugs (aspirin, clopidogrel), angiotensin-converting enzyme inhibitors, and statins are 
recommended for all persons with PAD. Lower extremity percutaneous transluminal angioplasty 
or bypass surgery is performed when advanced stages are reached and limb-threatening ischemia 
occurs. Once gangrene develops, amputation is necessary to prevent infected and dying tissues 
from causing septicemia. Therefore, accurate and timely diagnosis of PAD is crucial in the 
prevention of further health consequences [8].   
1.2.2 Current diagnostic techniques 
1.2.2.1 Ankle brachial Index 
The first-line diagnostic test for determination of PAD is the ankle brachial index (ABI) [8]. The 
ABI is calculated by measuring the maximum systolic blood pressure at the ankle and dividing it 
by the systolic blood pressure in the brachial artery in the upper arm. In healthy individuals ABI 
values range between 0.9 and 1.2. Values less than 0.9 identify patients with some form of 
vascular occlusions or stenoses. Most patients with symptoms of claudication will have an ABI 
between 0.5 and 0.8 and those with more severe symptoms such as rest pain will generally have 
values less than 0.5. 
Although the ABI is often useful in the diagnosis and determination of the severity of PAD, 
it has major shortcomings [8, 9]. The presence of distal emboli, micro-emboli and atherosclerotic 







close to 1. Furthermore, falsely elevated ABI readings occur in patients with medial wall 
calcification, a condition commonly seen in patients with diabetes, and renal insufficiency. In 
these cases, the ABI reflects the ability of the vessel wall to resist compression rather than being 
a true indicator of the blood flow and pressure within the vessel. A recent study involving 
diabetic patients with neuropathy [8] showed that ABI’s inability to detect arterial disease 
resulted in false-negative results in one third of the limbs. Consequently, physicians rarely 
employ this test in diabetic patients. 
 
Figure 1-1  Ankle brachial index being measured on the dorsalis pedis artery of the foot. 
 
1.2.2.2 Pulse-volume recordings 
Pulse-volume recordings (PVR) are conducted using segmental limb pressure cuffs along with 
the ABI measurement in an attempt to localize a stenosis or occlusion.  Limb pressure cuffs are 
placed on the thigh, calf, ankle and the metatarsal region of the foot.  These pressure cuffs are  
then inflated sequentially to 65mmHg and a plethysmographic tracing is recorded at the various 
levels (Fig. 1-2). The shape of the tracing should consist of a systolic upstroke and a rapid down 
stroke with a prominent dichrotic notch.  With increasing severity of PAD, the waveforms 







below represents a typical ABI/PVR test conducted at a vascular lab. We see the waveform 
traces at segmental locations along the lower extremity for both the right and left side of the 
patient.  The patient shown in Fig. 1-2 is a diabetic PAD patient who suffers from arterial 
calcifications and stiffening, which complicates his diagnosis.  By inspecting both the right and 
left extremities’ reactions to the thigh cuff (waveforms in the top boxes), we observe that the left 
leg (right top box) has a significantly higher amplitude waveform than the right leg (left top box).  
 
Figure 1-2  This figure shows the pulse volume recording waveforms for a patient with PAD and diabetes. 
Comparing the right and left extremities’ reactions to the thigh cuff (top boxes), we observe that the left leg (right 
top box) has a significantly higher amplitude waveform than the right leg.  However as we approach the bottom of 
the extremities, the left leg has a higher ABI value than the right leg.  Since the waveforms appear to be better in the 
left leg (right set of boxes) but the right leg has a higher ABI value, the physician would suspect that the ABI value 
is a false negative value and would continue to monitor this patient both over time and with other diagnostic 
modalities. 
 
However, as we approach the bottom, the left leg has a higher ABI value than the right leg.  
Since the waveforms appear to be higher amplitude in the left leg (right set of boxes) but the 







value is a false negative value and would continue to monitor this patient both over time and 
with other diagnostic modalities. 
 
Figure 1-3  Duplex ultrasound scan being conducted along the lower extremities. 
 
1.2.2.3 Duplex ultrasound 
Imaging methods are usually used as second line diagnostic tests, to confirm initial diagnostic 
results and to assess for a potential surgical intervention [10]. Typically, lower limb Duplex-
ultrasound (DUS) examinations are initially performed first to determine the location of stenosis 
or occlusions in the legs. DUS is a combination of B-mode and Doppler ultrasound and is useful 
in detecting lesions along the lower extremities. The technician will look for occlusions and 
listen for bruits (“wooshing” sounds) resulting from blood flow through narrowed arteries. DUS 
is used to identify lesions within the leg (Fig. 1-3), however the arteries below the knee are small, 
which makes the DUS assessment difficult. As the arteries decrease in size the results become 
heavily user dependent. Furthermore, identifying lesions does not provide direct information on 
the perfusion of the foot [11]. 
1.2.2.4 Angiography 
If this examination is inconclusive (e.g. DUS fails to visualize up to 15% of arterial segments in 







location and extent of arterial stenoses or occlusion in the leg [12]. CTA provides images of the 
vasculature in great detail, however CTA uses a potentially nephrotoxic contrast agent which 
imposes the risk of renal failure and is contraindicated in patients with renal insufficiency, a 
common concern in the diabetic population [1]. In addition, the cost and the use of ionizing 
radiation prevent CTA from being used as a screening or monitoring modality.   
 
Figure 1-4  CT Angiogram of the lower extremities 
 
The current gold standard in PAD diagnosis is called digital subtraction angiography 
(DSA). DSA is conducted on all patients being considered for amputation to determine whether 
revascularization is an option.  In DSA, a contrast agent is injected invasively, intra-arterially 
(usually through the femoral artery) to the patient and to obtain an image of the vasculature.  
DSA is invasive and also requires nephrotoxic contrast media. In addition, it also requires 
ionizing radiation, which limits DSA’s frequency of use. 
The use of ionizing radiation can be avoided by performing magnetic resonance 
angiography (MRA). However, since in this case another nephrotoxic contrast agent is used 
(gadolinium), concerns in diabetic patients as well as those with renal insufficiency remain. 







While MRA provides details of the blood circulation in the upper and lower limb, direct 
information about perfusion in the foot is not provided. MRA is also the most expensive of the 
imaging methods precluding it from use for screening and monitoring patients [10, 13]. 
 
 




In summary, current diagnostic techniques have several shortcomings when evaluating diabetic 
patients [8, 10, 11, 13].  They do not function when the patients have calcified (incompressible) 
arteries, such as diabetic patients, the population that has the greatest need for monitoring and 
detection. They often require the use of a contrast agent or expose the patient to ionizing 
radiation.  Furthermore, they do not give information about the overall foot perfusion within the 







system. Unlike current techniques this system will be able to image independently of arterial 
compressibility, and will not require a contrast agent or the use of ionizing radiation. In addition, 
it will allow the physician to visualize the perfusion response of the foot, giving spatial 
information to where blood is most deficient. A summary of the advantages of the VOTI system 
is outlined in the Fig. 1-5. 
 
1.3 Vascular optical tomographic imaging 
1.3.1 Light-tissue interactions 
Light can be absorbed and/or scattered as it propagates through tissue.  The amount of absorption 
and scattering is dependent on the tissue properties, as well as wavelength of light used.  These 
properties are represented by the absorption coefficient (!!), the scattering coefficient (!!) and 
the anisotropy factor (g).  
1.3.1.1 Absorption 
As light propagates through a medium (e.g. tissue), photon energy is taken up by the medium.  
This transformation of the electromagnetic energy into internal energy of the absorber (e.g. 
thermal energy) is referred to as absorption.  The reduction of light intensity of the propagating 
light by absorption is referred to as attenuation.  To quantify this effect an absorption coefficient 
(!!) is used to represent the probability per unit length of a photon being absorbed.  For a tissue 
comprised of N absorbing chromophores the total absorption of the tissue at a given wavelength 











Therefore by measuring the absorption coefficient at N wavelengths, it is possible to solve for 
the concentrations of the optically absorbing chromophores (ci).  
The intensity of light transmitted through a layer of material is governed by the Beer-
Lambert law.  The Beer-Lambert law states that the measured intensity of light (I) that has 
traveled through a layer of material with thickness x is related to the incident light intensity (I!) 
according to the inverse exponential power law 
 I = I!e!!!! (2) 
where !! is the absorption coefficient of the medium.  
1.3.1.2 Scattering 
Tissue scatters visible and near infrared light as it propagates.  This scattering is caused by 
random spatial variations in tissue density, refractive index and dielectric constant.  Actual light 
distributions can be significantly different from distributions estimated using the Beer-Lambert 
Law.  Light scattered from a collimated beam undergoes multiple scattering events as it 
propagates through tissue.  The scattering properties of a medium are described by its scattering 









Figure 1-6  A photon getting knocked off of its trajectory due to a scattering event.  The photon’s forward direction 
is retained after the scattering event is determined by the cosine of the deflection angle. 
 
1.3.1.3 Anisotropy 
The anisotropy factor (g) represents the forward direction retained during a single scattering 
event within a medium.  If a photon trajectory is interrupted by a scattering event with a 
defection angle θ, the forward direction retained in the new trajectory is given by the cosine of 
the deflection angle (Fig. 1-6).  The mean value of the cosine of the average defection angle is 
defined as the anisotropy.   
The scattering pattern by which photons scatter is represented by the phase function p(θ).  
The phase function is a function of the deflection angle from the photon’s original trajectory.  
The mean cosine is given by  




The scattering coefficient !! can be simplified by using the anisotropy of the scatter as given by 
the mean cosine g.  To simplify directional affects the reduced scattering coefficient !!!  is often 







 !!! = !!(1− g) (4) 
Light scattering in tissue is not isotropic, it is strongly forward directed. Total forward scattering 
means g = 1 and isotropic scattering means g = 0.  For tissues at visible and near-infrared 
wavelengths, g is generally between 0.7 and 0.99. 
1.3.2 Introduction to optical tomography 
In diffuse optical tomography (DOT) red and near-infrared light (650nm < λ < 900nm) are used 
to probe biological tissues [14]. This wavelength range is special because light absorption is 
relatively low. This enables the light to penetrate deep within tissue despite its large wavelength.  
The absorption coefficient increases rapidly as the wavelength of light deviates from the NIR as 
can be observed in the absorption spectra in Fig. 1-7. 
 
Figure 1-7  This image shows the absorption spectrum of the major intrinsic chromophores in tissue, within the NIR 
wavelength range. 
 
In DOT low energy electromagnetic radiation (~1 to 2.5 eV) is delivered to one or more 
locations on the surface of the body part under investigation and transmitted and/or back-
reflected light intensities are measured [14-17].  As the NIR light passes through tissue it is both 







propagation in tissue, we can derive the absorption coefficient (!!) and the scattering coefficient 
(!!) for the tissues of interest.   
By illuminating the tissue from various spatially distributed source positions and 
measuring the transmitted and reflected light at a number of detector positions surrounding the 
sample, DOT generates 3D spatial maps of the absorption (!!, typically 0.01-1 cm-1) and 
scattering (!!! , typically 10-100cm-1) of tissue.  
Using multiple wavelengths we are able to extract the effect of certain chromophores 
within the body. Of special interest are the blood constituents oxy-hemoglobin (HbO2) and 
deoxy-hemoglobin (Hb), which have distinctly different absorption spectra in the visible and 
near-infrared wavelengths (Fig. 1-7).   
Tissues require oxygen to function and the blood delivers that supply via red blood cells 
(RBC). RBC deliver oxygen to tissues by attaching oxygen from the lungs to hemoglobin 
proteins.  Upon reality to the tissue, the oxygen dissociates from the RBC to leave deoxy-
hemoglobin.  This information can inform the user about the health of tissue, non-invasively and 
without contrast injection.   
By performing measurements at multiple wavelengths, we obtain the following equations 
 !!" = ε!"!!!" × HbO! + !ε!"!"×[Hb] (5) 
 !!" = ε!"!!!" × HbO! + !ε!"!"×[Hb] (6) 
Rearranging to solve for hemoglobin we obtain 
 [Hb] =
ε!"!!!" !!" − ε!"!!!" !!"
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(8) 
In addition, derived parameters such as total hemoglobin  
 [HbT] != ! [HbO!] !+ ! [Hb] (9) 
and oxygen saturation 
 SO! =
[HbO!]
[HbT]  (10) 
can be obtained [18].  
By gathering data at different wavelengths and using multi-wavelength image 
reconstruction codes, 2 and 3-dimensional maps of these and other parameters, such as blood 
volume, can be generated [19-31]. The DOT imagers in this thesis will be referred to as vascular 
optical tomographic imaging (VOTI) systems. 
 
1.3.3 Imaging methods in diffuse optical tomography 
There are three different modes in which diffuse optical tomography can be conducted, time-
domain imaging, frequency domain imaging and continuous wave imaging.  All these methods 
have advantages and disadvantages in terms of hardware complexity, amount of information, and 
acquisition speeds.  In time-domain imaging, complex electronics are used to capture light as it 
propagates through the tissue and bins the intensity as it is received over time [32-38].  The 
output is a temporal point spread function (TPSF) whose shape is proportional to the optical 
properties of the tissue.  This broadened pulse represents a histogram of the time each photon 
took to travel from the source to the detector. A broader TPSF profile implies a very high 







light to reach the detector. A thin TPSF profile implies a high absorbing medium because all the 
highly scattered photons are absorbed before they can reach the detector. This imaging technique 
provides the most information, as the output is an entire profile of intensities over time, however, 
this comes at the cost of complicated electronics and slow frame rates. 
In frequency domain imaging the light source used is modulated at a high frequency (1-
100MHz) and upon detection both the amplitude change and the phase shift can be extracted [39-
46].  Since the effects of absorption and scatter on phase are different, this data is used to 
determine the scattering and absorption coefficient of the tissue of interest.  This method is 
simpler electronically, however it provides less information than the time-domain system. 
In continuous wave (CW) imaging, an un-modulated, DC light source is used to 
illuminate the tissue. Only the amplitude difference is collected and analyzed. This is the 
simplest of the three types of DOT imaging, however it provides significantly less information 
resulting in cross-talk between the effects of scattering and absorption.  The simplicity of the 
electronics allows for much more rapid acquisition and makes CW imaging ideal of dynamic 
imaging.  With instrumentation [31, 47-49] geared specifically to the fast data acquisition rates 
required for dynamic imaging, this technique has increasingly been applied to other clinically 
relevant areas, such as breast imaging [31, 49] and arthritis detection [50]. 
 
1.3.4 Optical tomography reconstruction techniques 
Image reconstruction in optical tomography is achieved by modeling how the light propagates in 
tissue.  Light scattered from a collimated beam undergoes multiple scattering events as it 
propagates through tissue.  Models can be used to simulate the transfer of energy through a 
turbid medium and predict the measurement data.  This is a heuristic approach based on a 







Image reconstruction algorithms are conducted using model based iterative image 
reconstruction (MOBIIR) schemes [51-53]. These schemes consist of three major parts.  First, a 
forward model for light transportation is used to predict the measured data. This model is a 
function of the distribution of optical properties inside the medium and the position and strength 
of the light source. Initially, an estimation of the distribution of optical parameters is used to 
calculate the first prediction of the measurement data.  
Secondly, a scalar objective function is evaluated to obtain a measure of difference 
between the predicted and measured data.  In the third step, the initial estimation of the optical 
properties is updated in a way that reduces the difference between predicted and measured data 
as defined by the objective function. These steps are repeated until a distribution of optical 
properties is found for which the objective function is minimal.  
The type of forward model being used in this work is based on the diffusion equation.  
This equation is derived from the radiative-transfer-equation.  The equation of radiative transfer 
is based on a conservation law that accounts for gains and losses of photons due to scattering and 
absorption. 
The fundamental unit of this equation is radiance ψ r,Ω  in units of [Watts/cm2/sr].  
Radiance is the quantity used to describe the propagation of photon power.  Radiance is the 
intensity at a spatial position and direction on the given domain.  In addition to radiance, there is 
a source function S r,Ω , the absorption coefficient, scattering coefficient and the phase function.  
The phase function p(Ω ⋅ Ω′) gives the probability that a single photon is deflected by an angle θ.  
The goal of any algorithm that solves the transport equation is to determine ψ r,Ω , or the 










 ϕ r = ψ r,Ω
!"
dΩ (12) 
which is the energy fluence rate. 
This is computationally expensive, due to complications arising from the numerical 
integration.  To simplify this equation we can expand angular dependence using spherical 
harmonics PN where N denotes the number of coefficients to use.  Using first order spherical 
harmonics derives the simplest form.  This form is called the Diffusion Approximation (DA).  
The DA holds true given that !! is large and !! is small and the point of observation is far from 
the boundary region. 
In other words the following criteria have to be met: 
1) The scattering length (1/!!) is small compared to the propagation distance of the light. 
2) !! << !!(1− g)  
The diffusion approximation is given by: 
 −∇ ⋅ D r ∇ϕ r + !! r ϕ r = S r . (13) 
Here D is the diffusion coefficient given by 
 D = 13(!! + !!′)
 (14) 







 ϕ− 2A n ∙ J = 0 (15) 
where n denotes the surface normal vecctor pointing outward and coefficient A accounts for the 
refractive mismatch at the air-tissue interface and the photon current J! r  is given by 
 J r = Ωψ r,Ω
!"
dΩ! ≃ −D(r)∇ϕ r  (16) 
This DA equation is ideal for foot imaging because the foot is large enough to assume that most 
of the light is diffuse by the time it reaches the detectors.  Furthermore, it is the only practical 
option in dynamic imaging, since 2000 frames are captured and the radiative transport equation 
would take weeks to complete the analysis of an individual subject. 
 
1.3.5 Camera vs. fiber based detection system 
In optical tomography both fiber and camera based detection techniques are used for imaging 
hardware. There are advantages and disadvantages to each with respect to performance, as well 
as functionality. Fiber based detection techniques allow for more flexibility as fibers can be 
placed anywhere, which enables easy capturing of reflection and transmission measurements 
without any additional optics [47, 48, 54-56]. Since each fiber can collect light in parallel the 
data can be acquired very rapidly.  Furthermore, each fiber is not affected directly by the 
intensity received by the other fibers increasing the dynamic range of fiber-based systems seems 
to >150dB.  It is this combination of configurability, fast acquisition speeds and high dynamic 
range that makes optical fibers an attractive choice for light detection.  Fiber based detection 
methods however require customized and often complicated electronics, which are generally 







source and detector positions that can be used simultaneously and the amount of data that can be 
recorded per patient.  Optical fibers also require good contact with the object being imaged. This 
can be quite cumbersome, especially when dealing with awkward geometries such as the foot, 
which vary greatly in shape and are not malleable. 
 
Figure 1-8 Vascular optical tomographic imaging system and the measurement probe. 
 
Camera based detection techniques seem to be increasing in popularity, as cameras are 
improving rapidly and can achieve similar dynamic ranges and acquisition speeds to their fiber 
based counterparts [38, 41, 57, 58].  There are two main types of cameras used currently, charge 
coupled device (CCD) cameras and CMOS cameras.  CCD cameras are more prevalent in DOT 
as they have much lower noise in their channels, which yields a higher dynamic range, and better 
performance in low light settings.  Cameras have the advantage of being commercially available 
and cheaper than fabricating an entire detection unit.  CCD cameras come in various pixel sizes, 







Instruments ProEM CCD cameras have a frame rate of 34 fps, despite having 262,1444 pixels).  
The camera system does not require direct contact with the object being measured and can be 
placed almost anywhere with the optics guiding light to it.  Despite lower dynamic range and 
acquisition speeds than fiber systems, camera systems contain large detection arrays and their 
contact-free characteristics make them great for use in clinical settings.  As cameras improve, 
their dynamic range and acquisition speeds continue to increase and will soon be a significantly 
better alternative to the fiber based detection units. 
 
1.3.6 Optical techniques in peripheral arterial disease 
Several groups have started to apply optical imaging techniques to address problems in PAD. 
Optical measurement techniques can non-invasively measure blood in tissue without the need for 
contrast agents or ionizing radiation. Promising initial results have been shown using near-
infrared spectroscopy (NIRS) to detect PAD [59-65].  In NIRS measurements are performed in a 
reflection-based geometry at isolated points on the surface of the tissue, which makes the 
technique heavily dependent on the location of the probe. In addition unlike optical tomographic 
imaging, NIRS does not provide the physician with a cross-sectional image blood-dependent 
parameters through the foot, but simply a time trace of the hemoglobin concentrations at a given 
measurement location. Recently indocyanine green (ICG) has been used to assess foot perfusion 
in research settings.  This is promising technology and has been used in the clinic [21, 66].  
However, this technique images on a more superficial level and requires contrast injection. We 
propose the use of vascular optical tomography imaging (VOTI) for the diagnosis and 







flowing within the foot, providing for better spatial information about the perfusion within the 
foot. 
1.3.7 Dynamic imaging system 
In this work, two CW VOTI systems were used to image PAD.  The first system is a pre-existing 
digital, fiber based VOTI imager described in [48]. The system illuminates the tissue with an 
optical beam consisting of two laser diodes (wavelengths λ=765 nm and 830 nm). The diodes are 
sequentially coupled into different 1 mm multimode fiber bundles that distribute light to multiple 
areas along the foot (Fig. 1-8). The current of each laser diode is modulated to a distinct 
amplitude and frequency (5-7 kHz). In this way, multiple wavelengths may be illuminated 
simultaneously, thereby increasing the imaging speed. The respective contribution to the 
attenuated detected signal can be extracted using synchronous detection techniques [67]. The 
detected signal is digitized early after detection and is filtered and demodulated using a digital 








2 Contact Based Imaging 
2.1 Measuring probe 
To adapt an existing dynamic VOTI system for foot imaging a new patient-system interface 
needed to be developed.  The design needed to accommodate the various foot sizes, while 
allowing for the extraction of the foot geometry and maintaining patient comfort.  I implemented 
several designs including a silicone rubber band, a hanging foot probe, an intralipid footbath, and 
an intralipid IV bag design (Fig. 2-1).   
The silicone rubber probe (Fig. 2-1A) is made from room temperature vulcanizing (RTV) 
silicone.  The silicon probe was created by mixing a two-part mixture together and letting it set 
in a 12 inch x 2 inch rectangular mold.  Upon solidifying, 32 adhesive cylindrical clamps were 
added to one side of the rectangle and served to hold the fibers in place.  On the opposite side a 
Velcro strap was added to tighten the probe onto the foot.  This probe was designed to wrap 
around the foot and attach the fibers onto the foot.  However, the probe did not wrap fully around 
the foot. It was not flexible enough and resulted in a tear-drop shape which would prevent some 
sources from making contact with the foot. In addition, the probe did not hold together well due 
to the weak Velcro connection and its flexibility made it difficult to extract the source and 
detector locations.   
The hanging foot probe (Fig. 2-1B) was built using acrylic to attach fibers onto the mid 
metatarsal level of the foot.  The probe worked by placing the subject’s foot onto a platform 
which could be elevated using two knobs to accommodate various foot sizes.  This moved the 
subject’s foot closer to the fibers until they made contact with the dorsal surface of the foot.  This 







the same direction, it created a torque on the foot; the fibers pressed into the foot causing 
discomfort.  In addition, the probe had a semicircular shape while the foot is more of a plane 
wing shape and a quarter of the fibers did not make contact with the foot. 
The intralipid footbath (Fig. 2-1C) probe was designed to bypass the fiber-coupling and 
geometry extraction requirements of the design.  The foot was placed inside a plastic box with 
fibers attached at the bottom, to illuminate the dorsal surface a knob would lower a set of fibers 
attached to the top.  Once the foot is placed in the box, a matching liquid (e.g. intralipid) would 
be placed to immerse the foot then the top fibers would be lowered to the surface of the matching 
liquid.  That way the height of the liquid could be recorded and a rectangular geometry would be 
placed in the reconstruction instead of the complex foot shape.  This design was not ideal for 
patients with open wounds, and physicians did not expect patients to consent to placing their feet 
in intralipid.  Furthermore, the large sizes of the foot require a lot of matching liquid, which can 
be expensive, in addition, the liquid needs to be refrigerated to prevent it from spoiling which 
can cause discomfort to the patient due to the temperature differential.   
Fig. 2-1D shows the intralipid IV bag design.  This design was intended to eliminate the 
geometry extraction problem while not having the foot come in direct contact with the intralipid 
solution.  However, when the IV bag was placed on its side, air bubbles floated to the top and 
caused too much interference in the imaging. Furthermore, the intralipid had to be stored at cold 
temperatures, and could not be heated directly in the bag causing discomfort when coming in 









Figure 2-1  Various measuring probe designs.  Finding a measuring probe design that can accommodate the various 
foot sizes and shapes, while being sturdy enough to not move during imaging and provide enough information to 
extract the imaging protocol lead to several different designs. A) This design featured a flexible silicon rubber that 
wrapped around the foot, however this design did not allow for extraction of source and detector locations B) This 
design was meant to hang on top of the foot with the patient lying down, however the weight of the fibers caused the 
probe to stick onto the patient’s foot and there was an air-tissue gap due to the foot’s non-semicircular shape.  C) 
This milk bath probe was designed to eliminate the need for matching the geometry, however some patients had 
open wounds and gangrene, which would preclude the use of the system in many patients. D) This intralipid IV bag 
design was intended to eliminate the need to match the geometry of the foot, however the use of intralipid and air 
bubbles in the bag caused too much interference in the imaging.  
 
 This sandal-shaped measuring probe was designed to accommodate the various shapes and 
sizes of feet seen in a clinical setting. Unlike breasts or small animals, feet are not malleable and 
due to PAD co-morbidities such as ulcerations and gangrene, feet cannot be placed in an 
intralipid matching fluid.  Utilizing a sandal-shaped design, 18 optical fibers (6 sources, 12 







remaining 16 fibers (8 sources, 8 detectors) are guided towards the surface of the foot via spring-
loaded shoulder screws (Fig. 2-2). The probe’s 14 sources and 20 detectors are placed in a two-
ring arrangement. This design gives each of fibers on top of the foot the ability to translate 
different lengths to make contact with the non-uniform curvature of the foot.  To obtain the mesh 
for the image reconstruction a photograph is taken of the patient’s foot such as shown in Fig. 2-2, 
using two references a coordinate system can be made to identify the locations the sources and 
detectors and the segment the foot boundary.  
 
Figure 2–2  Drawing of the measuring probe and the extracted foot mesh. 
 
The final measuring probe design is another sandal shaped design, however instead of using 
springs to account for the variable distances each fiber must travel, aluminum rods are guided by 
a clamping mechanism at an arch as well as when touching the foot.  This new clamp design 
allows more degrees of freedom and facilitates making good contact between the tissue and the 
fiber (Figure 2-2).  This probe had 4 source and 4 detector fibers that attached to the dorsal 
surface of the foot and 6 sources and 12 detectors on the plantar surface.  In this design the fibers 
on the plantar surface are placed closer together than the previous spring-loaded design so that 








Figure 2-3  Image of the modified imaging probe, showing the additional degrees of freedom given to the fibers. 
This allows for faster imaging setup and better fiber contact with the patient. 
 
2.2 Dynamic imaging protocol 
A dynamic imaging protocol was designed to image the hemodynamics of PAD patients.  
Subjects were asked to place their foot on the patient interface (Fig. 2-3), while sitting upright in 
a chair. A total of 26 fibers (10 source and 16 detection fibers) encompassed the foot, forming a 
coronal cross-section at the mid-metatarsal level.  This location was chosen because it contains 
the major arteries of the foot the dorsalis pedis and the major branches of the posterior tibial 
artery. Physicians often probe these arteries when measuring a patient’s ABI.  Furthermore, it is 
a common location for diabetic foot ulcers to occur and the vasculature in that region is too small 








Figure 2-4  Five stage measurement protocol used for VOTI clinical study 
 
After positioning the probe around the patient’s foot, the instrument automatically 
determined and stored the ideal gain settings for each channel at every source position. To illicit 
a controlled vascular response a pressure cuff was applied to the upper thigh. Patients are 
familiar with leg cuffs from ABI measurements, making this dynamic protocol a natural 
extension of the existing diagnostic procedures.  The protocol consists of five stages as outlined 
in Fig. 2-4.  First a baseline measurement was taken while the patient is seated at rest for 
approximately one minute. Second, the pressure cuff is inflated to 60mmHg around the thigh. 
This induces venous occlusion, allowing arteries to supply blood the foot but preventing the 
veins from returning it to the heart, causing the blood to pool in the foot. The pressure was 
maintained for one minute after which it was rapidly released. During the third stage of the 
sequence, the foot was left to recover for one minute. In the fourth portion of this protocol a 
120mmHg was applied to the thigh inducing greater venous occlusion for one minute. Then the 
pressure was released and the foot was left to recover.  This five stage protocol was applied three 
times for each subject to show repeatability. This sequence was chosen because physicians and 
patients are familiar with pressure cuff applications from previous experiences with ABI and 







institutional review board (IRB) of the New York Presbyterian Hospital and written consents 
were obtained from all patients.   
 
2.3 Signal pre-processing 
The detector readings were filtered by using the discrete cosine transform for noise suppression 
and elimination of artifacts due to movement or respiration. A discrete cosine transform (DCT) 
expresses a sequence of finite data points in terms of a sum of cosine functions oscillating at 
different frequencies.  It relates to the Fourier transform but uses only real valued coefficients 
[68].  
The DCT coefficients C u  for a 1D signal f x  of length N are calculated using the formula 




for u = 0,1,2,… ,N− 1. 
Similarly, the inverse transformation is defined as 











 a u =
1
N , u = 0
2
N , u ≠ 0.
 (19) 
The coefficients C u  that yielded a high correlation with the original signal were used to 
represent the image, which enabled the feature-preserving noise reduction similar to a low-pass 
filter without the loss of curvature within the original signal. These coefficients used were 
different for each subject and on average less than 25 coefficients were needed to represent the 
signal. This preprocessed data was then inputted to the image reconstruction code. 
 
2.4 Image reconstruction algorithm 
In biological tissue, the tissue absorption is determined by a sum of contributions from 
absorbers present in tissue as given below: 
 µa = εiCi = ε!" #$
i
∑ C!" #$  (20) 
where εi and Ci  denote the molar extinction coefficient and the concentration of the i-th 
chromophore, respectively. In the multi-spectral inverse model, one can directly recover a spatial 
distribution of chromphore concentrations by employing data obtained from measurements at 
multiple wavelengths simultaneously. Accordingly, the associated inverse problem can be 
formulated into the general constrained optimization problem as:  
 min f (Ci ) =
1
2
(Pλ − zλ )
T (Pλ − zλ )
λ







where Ci  is the i-th chromophore concentration that can be either [HbO2] or [Hb] or [Water] or 
[Lipid] concentrations, and AI=b is the constraint representing the discretized ERT, and Pλ  and 
zλ  are the predictions and measurements at wavelength λ. The common way to solve (21) is to 
eliminate the constraint first and then solve the resulting unconstrained problem (that is a 
function of Ci  only) by using any nonlinear optimization schemes, which results in a highly cost-
demanding process.  
In the PDE-constrained multispectral approach, we solve the PDE-constrained problem 
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∑ (AI −b)λ  (22) 
where ϕλ is the estimate of the Lagrangian multiplier. Let xk = (Ci , I )  be the current iterate and we 
denote ∇Ci f  by  gk and ∂Fk ∂xk  by Fk ,x . The SQP method finds the next step Δx = (ΔCi ,ΔI )  through 
the minimization to a quadratic approximation of the Lagrangian function L  subject to the 
linearized constraints:  
 min   gkTΔxk +
1
2
ΔxxT Lxx (xk ,ϕ x )Δxx    subject to   (Fk ,Ci )ΔCi ,k + (Fk ,I )ΔIk + Fk = 0 . (23) 
Instead of using the full-space approach (23) we employed the reduced-space Hessian approach 
here to give a simultaneous update of the forward and inverse variables as: 
 
xk+1 = xk +γ kΔxk
Ik+1 = Ik +γ kΔIk
 (24) 







Two dimensional reconstructions were derived from the measurement data on a 6000 
element mesh, using a partial differential equation (PDE)-constrained multispectral imaging 
method [49]. This method solves the forward problem (boundary radiance at each wavelength) 
and the inverse problem (spatial distribution of chromophores concentrations) simultaneously 
using a reduced Hessian sequential quadratic programming (rSQP) method [49, 69].  
The forward problem used is the diffusion approximation to the equation of radiative 
transport to model the light propagation in tissue.  This scheme directly reconstructs the spatial 
distributions of the oxy and deoxy-hemoglobin concentrations in the foot. Note that the 
differences in [HbO2] and [Hb] obtained through reconstruction is relative to baseline which is 
assumed to be given by [HbO2] = 23.43µM and [Hb] = 14.69µM, throughout the foot.  
While these values may differ between subjects, this study is more concerned with 
hemodynamics and therefore relative changes during stimuli.  All reconstructions are shown in 
percent changes relative to the baseline period. A radial basis function (RBF)-type regularization 
scheme is employed to obtain quality images by reducing image noise such as artifacts near the 
foot surface. More details about this code can be found in reference [69].   
The spatial resolution at the center of an optical tomography reconstruction is 1/10th the 
outer diameter of the object being imaged.  Given our source-detector configuration, and the 
geometry and optical properties of feet in the wavelength region considered, we expect spatial 
resolution of approximately ~0.5cm in the center of the feet, and ~0.2cm towards the surface 








2.5 Case study using VOTI 
We first performed a case study to test the efficacy of detecting PAD within the lower 
extremities. Three patients were selected: a healthy volunteer, a PAD patient without diabetes 
and a PAD patient with diabetes.  The physicians diagnosed the subjects based on a combination 
of the patients’ ABI readings, segmental ultrasound waveforms and physical symptoms and 
medical history.  
2.5.1 Light intensity time traces 
We present three select cases, one patient with PAD (ABI = 0.66), one patient with diabetes and 
PAD (ABI = 1.07) and one healthy subject (ABI = 1.00). Using the traditional ABI measurement 
it is possible to discern between the healthy control and the PAD patient, however the diabetic 
PAD patient is not distinguishable. Diabetic patients often have incompressible arteries due to 
calcifications which result in elevated ABI readings and leads to false negative diagnoses.  
Fig. 2-5 shows the representative time traces for the healthy, PAD, and diabetic PAD 
subjects respectively. The detector readings shown are normalized to the first 30 seconds of the 
initial rest period. The time traces have five distinct phases that correlate with the measurement 
protocol shown in Fig. 2-4. Initially, we see a flat segment in concordance with the rest period. 
Subsequently upon applying the 60mmHg thigh cuff (inducing venous occlusion), we see a drop 
in intensity. During venous occlusion, blood is pumping from the arteries into the foot but not 
returning to the heart, it pools in the foot. The greater blood volume in the foot increases the light 
attenuation resulting in the drop of signal observed during the venous occlusion stages of the 
measurement protocol. After one minute of occlusion the thigh cuff is released enabling the 







to the thigh inducing greater blood pooling and a greater drop in detector intensity for about one 
minute before release allowing the signal to return once again to rest.   
 
 
Figure 2-5  Normalized Detector Readings (different detector positions shown as colored lines) for a Single Source 
Illumination over time for (A) a healthy subject, (B) PAD patient, and (C) a diabetic PAD patient. The individual 
traces were filtered with a 50-point moving average filter. A dip in intensity is observed at approximately 1 minute 
when the 60mmHg cuff is applied to thigh. This impedes blood from returning to the heart and causes it to pool in 
the leg increasing light absorption. Upon release of the cuff the signal returns to baseline the same behavior can be 
seen with the 120mmHg cuff. There are clear differences in the magnitude drop during thigh occlusions as well as 
the recovery rates from release of the thigh cuff.  
 
During both the 60mmHg and 120mmHg occlusions the healthy volunteer had a 
significantly greater percent drop in detector intensity (20% and 45%) than the PAD Patient 
(10% and 15%) and the diabetic PAD Patient (20% and 20%). These amplitude drops were 
calculated by observing the largest magnitude change among the different detectors for the same 
source position before the release of the 60mmHg and 120mmHg pressure occlusions 
respectively. The detector readings reflect the amount of light that passes through the tissue. The 







directly proportional to the total hemoglobin concentration this implies that more blood collects 
in the foot during occlusion in the healthy subject than in the patients with affected vasculature. 
Furthermore, the decay and recovery rates of the detector intensities differ between the three 
subjects. The healthy volunteer exhibits a fast decay in the detector intensity and the occlusion 
rate has a distinct plateau phase while the PAD patients exhibit a more linear trend. It is 
suspected that the PAD patients exhibit a more linear trend because the diseased arteries provide 
greater flow resistance due to plaque build up and a lack of arterial wall capacitance due to 
arterial wall calcifications. Despite the similarity in the ABI measurements of the diabetic PAD 
patient and the healthy volunteer, DDOT detector readings provide contrast between the two 
subjects providing useful information that is missing within the current diagnostic methods. 
2.5.2 Total hemoglobin concentration image reconstructions 
The detector readings from multiple source positions were used to reconstruct two-dimensional 
cross-sectional image of the change in total hemoglobin concentration [HbT] within the foot.  
These reconstructions will inform physicians about the perfusion within the foot and provide a 
more comprehensive methodology for identifying regions of malperfusion.  
 
 
Figure 2-6  The locations of hemoglobin change within the 2D reconstructions correlate with the expected anatomy 








Fig. 2-6 shows a side-by-side comparison between an anatomical cross-section adapted 
from an anatomy textbook and a healthy foot reconstruction image. The changes in hemoglobin 
concentration occur in the periphery of the foot as expected anatomically.  This supports our 
hypothesis that VOTI will be capable of localizing the blood volume within the foot and help 
inform physicians about the overall effect of their procedures on the well being of the foot. 
Fig. 2-7 shows the image reconstructions at six time points during the 120mmHg thigh 
cuff occlusion.  In these images we can see the hemoglobin concentration gradually increasing 
within the foot during the occlusion portion of the imaging sequence and then decreasing back to 
baseline upon removal of the pressure cuff. The healthy subject, PAD patient and the diabetic 
PAD patient exhibit different time courses with respect to both intensity and rate of change of the 
hemoglobin concentration. The healthy subject has the largest magnitude transition from the 
beginning of the occlusion to right before the cuff removal at the fourth time point.  Furthermore, 
the amount of blood in the foot made a full recovery back to resting state.  The PAD patient 
exhibits a slower rate and magnitude of blood pooling before the release of the thigh cuff than 
the healthy patient. This is expected due to the affects of plaque accumulation in the arteries 
impeding the blood flow. The diabetic PAD patient had a slower rate and the dynamics were not 
nearly as apparent.  
The initial change in concentration of hemoglobin within the foot was relatively high 
before the 120mmHg occlusion; this is most likely due to an incomplete recovery from the 
previous 60mmHg occlusion. Physiologically the incomplete recovery can be caused by 
obstructions of the capillary bed of the foot.  We suspect that these microvasculature occlusions 
maybe cause the blood to remain in the foot and not flow to the veins during the 60mmHg 









Figure 2-7  Dynamic changes occurring during the 120mmHg occlusion within the cross section of the foot along 
the course of the imaging sequence. There appears to be a faster reaction to the thigh cuff within the healthy foot 
than the feet with the affected vasculature as well as a greater change in the total hemoglobin concentration. 
 
Looking at the blood volume dynamics within the foot, we see that the two time points 
prior to release of the thigh cuffs show the most significant differences between the three cases. 
Fig. 2-8 shows reconstruction results before the release of the 60mmHg pressure, and before the 
release of the 120mmHg pressure. These images show clear differences between the healthy 
patient and the two PAD patients. We observe that the changes in [HbT] are much less 
pronounced in the feet of the PAD patients than the healthy volunteer. This suggests that there is 
significantly less blood pooling in PAD patients’ feet during a minute of venous occlusion. 
Physiologically we suspect that the differential is due to the blood flow impedance caused by 
plaque in the affected vasculature as well as arterial stiffening due to calcifications within the 









Figure 2-8  2D Reconstructions of the Total Hemoglobin Concentration [HbT] for Healthy volunteer, PAD patient 
and a Diabetic PAD patient. There is more hemoglobin present within the healthy volunteer than the two patient 
cross sections shown below it.  
 
 To further quantify the hemodynamic change within the feet we calculated the sum of the 
[HbT] in each frame of the dynamic imaging sequence and obtained an area weighted average 
signal (Fig. 2-9).  We recover the five phases of our imaging sequence in the weighted average 
signals.  These time traces show that the amount of blood within the foot increased when the 
thigh cuff was applied to the foot (phases 2 and 4 in all images in Fig. 2-9). The concentration of 
hemoglobin in the foot during thigh occlusions is greatest within the healthy volunteer (Fig. 2-
9(A)), in concordance with the time-dependent detector readings. Furthermore, the patients with 










Figure 2-9  Area weighted Average Total Hemoglobin Signal Healthy for (A) Healthy Volunteer, (B) a PAD patient, 
and (C) a diabetic PAD patient.  We recover the five phases seen in the raw detector time traces and observe more 
blood pooling within the healthy volunteer than the patients with affected vasculature. 
 
2.5.3 Regions of hemodynamic consistency 
To better quantify which regions in the foot contribute most to the area weighted average 
changes, we calculated the cross-correlation coefficients between the area weighted average 
change in [HbT] over the whole cross section (see Fig 2-9) and the change in [HbT] for each 
pixel within the cross section over time sing the equation 
  (25) 
where h(t) is an individual pixel time trace from within the foot and W(t) is the weighted average 
signal from the entire foot (both time series are of length N.) The pixels that contribute the most 
to the area weighted average change (here defined as ρ>0.7) are plotted in red in Fig. 2-10.  
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Figure 2-10  The image shows a healthy foot with a hemoglobin time trace being extracted from it.  The cross-
sectional image shown is a binary image where the red pixels represent regions within the foot that have a high 
correlation coefficient with the externally measured signal.  We show an example of extracting a hemoglobin time 
trace from a pixel region of interest, which can be used to assess foot perfusion.  If a physician was interested in how 
a certain region of the foot is behaving, he or she has the option of selecting the region and seeing the time course 
associated with those pixel intensities. 
 
These regions of hemodynamic consistency (RHC) show the spatial locations that 
correspond to the vascular response, eliminating potential artifacts and background noise.  We 
observe that the RHC pool together are not arbitrarily dispersed throughout the image.  This 
implies that they most likely correspond to a vascular structure.  By averaging the pixels within 
the RHC instead of the entire foot cross section, it is possible to obtain more pronounced signal 
along with the location in the foot to which they correspond. 
This analysis could also be used as a diagnostic tool.  By counting all pixels with ρ>0.7, 
we find that in a healthy subject and the PAD patient both have 22.5% of their pixels correlating 
to the weighted average signal, while the Diabetic PAD has only 6.18% of its pixels correlating 
with the weighted average signal. This suggests there is a severe difference in the hemodynamics 








Figure 2-11  Pixels that correlate with Weighted Average Total Hemoglobin Signal and their corresponding time 
traces for (A) a healthy volunteer, (B) a PAD patient, and (C) a diabetic PAD patient.  By using RHC we see cleaner 
signals than the weighted average signals and the differences in the vascular dynamics become much more apparent. 
 
 Taking the weighted average signal within the RHC (shown in red in Fig. 2-11) we obtain 
the adjacent time traces. The signals from within the RHC show cleaner signals for the three 
different cases, these signals coincide more with the vasculature of the foot and are less 
adulterated by noise and artifacts.  The healthy volunteer shows the highest concentration of 
blood pooling during the occlusions and has a significantly faster occlusion and decay rate. 







occlusions but has a slower occlusion and decay rate than seen in the weighted average total 
hemoglobin signal within the whole foot. The diabetic PAD patient has the lowest concentration 
of hemoglobin change and the concentration of hemoglobin does not return fully to rest within 
the one-minute recovery time of the imaging sequence. 
 
 
Figure 2-12  Frequency spectrum analysis of hemoglobin time trace 
 
To further validate that these images do correlate with the vasculature of the foot we 
calculated the Fourier transform of each pixel’s intensity over time and summed the resulting 
spectrums together. The resulting net frequency spectrum for the healthy subject can be seen in 
Fig. 2-12. The figure contains two well-defined peaks within proximity to 1 Hz.  This provides a 
direct connection between the RHC and the foot vasculature, as 1 Hz is the average resting 
human heart rate. There are two peaks that occur within the typical human heart rate zone, which 
may indicate that the subjects’ heart rate increased as the pressure cuff was applied or possibly 
that they were anxious at the beginning of the imaging protocol and became more relaxed at the 







2.5.4 Modeling vascular response 
To simulate the effect of a thigh cuff occlusion on the vasculature, we created a Windkessel 
model.  Windkessel models describe the heart and the systemic arterial system as a closed 
hydraulic circuit. The hydraulic circuit contained a water pump connected to a chamber, filled 
with water except for a pocket of air. As it is pumped, the water compresses the air, which in turn 
pushes the water out of the chamber. This analogy resembles the mechanics of the heart [72, 73]. 
Windkessel models are commonly used to represent the load undertaken by the heart 
during the cardiac cycle. It relates blood pressure and blood flow in the aorta, and characterizes 
the arterial compliance, peripheral resistance of the valves and the inertia of the blood flow [74-
77]. This can be used to model the vasculature changes due to vasodilator or vasoconstrictor 
drugs, development of mechanical hearts and heart-lung machines or pressure cuff applications 
[78-81].  
We built a multi-compartment Windkessel circuit for vascular model (Fig. 2-13) to 
simulate the effect of a pressure cuff on the vascular network.  Parameters were changed in the 
model to verify the different responses of the healthy, PAD, and diabetic-PAD subjects [74].  
Our Windkessel model takes into consideration two major parameters: 
• Arterial Compliance: refers to the elasticity and extensibility of the major artery during 
the cardiac cycle. 
• Peripheral Resistance: refers to the flow resistance encountered by the blood as it flows 
through the systemic arterial system. 
In the electrical analog, the arterial compliance (C in cm3/mmHg) is represented as a capacitor 
with electric charge storage properties and the peripheral resistance of the system arterial system 







(electrical current) is driven by the pressure gradient (voltage) between each compartment. When 
the pressure increases the vascular compartment expands and the flow of the blood increases. 
This is analogous to the relationship between voltage and current given by Ohm’s Law.  
Our model was built in MATLAB Simulink Software (Fig. 2-13). It contains four 
branches, each one built with two resistors and a capacitor. The branches represent arteries, 
capillaries and veins as well as an arteriovenous (AV) shunt, also known as an AV fistula.  The 
AV shunt is a vessel that is created when plaque obstructs the flow of the blood from the arterial 
system into the venous system to prevent this obstruction, revascularization occurs to bypass the 
buildup.  We use two voltage generators: P! represent the arterial blood pressure, P! means the 
venous blood pressure. We connect the P! voltage generator function to simulate the dynamic 
response due to the cuff pressure that we attend.  The blood flows from the artery to the 
capillaries and into the veins or from the artery directly to the vein via the AV shunt depending 
which path has the least resistance [6, 82-85].   
PAD occurs due to plaque accumulation in the vascular walls. The resistance within the 
artery increases as the functional radius of the arteries decrease due to the plaque and the blood 
flow is reduced.  Following arterial occlusions, local microcirculatory changes occur; a 
breakdown of microcirculatory flow regulation results in mal-distribution of blood flow, 
capillary hypertension with excessive fluid filtration. When plaques limit the blood flow, 
alternative paths develop.  In our model, the shunt represents the alternative vascular conduit for 
blood to flow. Patients often develop AV shunts when they have severe PAD, shunts are also 
known as fistulas.  In addition, the hardening of the arterial wall is due to various depositions 







arteries decrease because the vessels lose their compliance and cannot expand in size to 
accommodate more volume. 
To account for this in our model we vary the resistance and capacitance of the vascular 
conduits and include an AV shunt for patients with affected vasculature.  For the healthy subjects 
we give a high resistance to the AV shunt so that it is the path of most resistance and the blood 
circulates from the arteries to the capillaries to the veins. When we analyze the PAD patients we 
have to consider that the artery is occluded due to the development of the plaque; the blood 
needs to follow other alternative path (revascularization), in this case the resistances value of the 
shunt are lowered.  The Windkessel model can be seen in Fig. 2-13. 
 
Figure 2-13: Multi-Compartment Windkessel Circuit for Vascular Modeling 
 
The vascular capacitance decreases because long-term diabetes provokes a decreased 
distensibility of peripheral vasculature. In our circuit models, the voltage in the capacitor will 
increase and decrease with exponential trend according too Kirchoff’s loop rule. 
• e
!
!!!!represent the charge of the capacitor 
• e!
!
!!!!represent the discharge of the capacitor 







The model was tested to view the effects of the two major parameters separately then we 
combined both the effects of resistance and capacitance together. First we tested the effect of 
resistance on our model. We increased the arterial and capillary resistance while keeping the 
resistances of the AV shunt constant.  The parameters for the simulation can be seen in Table 1. 






Ra_1 1 50 150 
Ra_2 2 60 180 
Rc_1 3 100 250 
Rc_2 3 100 250 
Rs_1 1000 1000 1000 
Rs_2 1500 1500 1500 
 
Table 1:  This table shows the values used in the resistance experiment.  Three trials were completed, the first was 
done with low resistance in the arteries and capillaries, the second with medium resistance and the third with high 
resistance. 
 
The results of the simulation can be seen in Fig. 2-14. The output of the low resistance 
scenario has a greater magnitude and reaction rate than the scenarios with medium scenario and 
high resistance.  This is the expected result, as greater plaque accumulation would inhibit flow of 
blood to the extremities slowing down and decreasing the amount of blood pooling in the foot 








Figure 2-14: Modeling results for increasing vascular resistance in the Windkessel Model.  We see that the there is a  
greater amount of blood pooling in the vasculature with less resistance (i.e. less plaque). 
 
 Ca low Ca medium Ca high 
Ca (mmHg/s/ml) 0.23 2 3 
Cc (mmHg/s/ml) 0.015 0.31 8 
 
Table 2: Parameters input into the Windkessel model to test the effect of compliance on foot perfusion. 
 
Second, we tested the effect of increasing vascular capacitance in our model.  Similar to 
the previous case, we ran three simulations with low, medium and high vascular capacitance and 
observed the effect of a pressure cuff application.  The parameters for this trial are shown in 
Table 2.  We found that the lower the arterial capacitance the faster the reaction was to the thigh 








Figure 2-15: Modeling output for decreasing the compliance of the vasculature.  There was a greater amount of 
blood pooling in the more compliant trials (less rigid/calcified arteries). 
 
Resistance Healthy 





Ra! 11 800 8000 
Ra! 12 120 1200 
Rc! 15 100 1000 
Rc! 15 100 1000 
Rv! 0.023 0.023 0.023 
Rv! 0.000023 0.000023 0.000023 
Rs! 10000 1 1 







Ca 2 0.70 0.080 
Cc 0.31 0.31 0.075 
Cv 13.3 13.3 13.3 
Cs 1/200 1 1 
Table 3: Parameters for resistance and capacitance input into the Windkessel model to simulate the vasculature of 








Having looked at the effects of resistance and capacitance individually, we change the 
values simultaneously to mimic the conditions of the patients that we expect to see the clinic. We 
chose appropriate values of the resistances because the current should follow the low-
resistance path as seen in Table 3, these values were derived from [86]. 
 
  
Figure 2-16  Results from the Windkessel model for a healthy, PAD and Diabetic PAD subjects.  We observe 
greater blood pooling and a faster reaction to the thigh cuff in the healthy subject. 
 
The resistance of the artery for Healthy, PAD, and diabetic PAD are: 
R!"#$%&' < R!"#!and!R!"#$%&"'!!"# 
And the capacitance of the artery for Healthy, PAD, and diabetic PAD are: 
C!"#$%&' < C!"# < C!"#$%&"'!!"# 








and the following rates for recovery 
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!This implies that healthy patient time traces will increases and decreases faster than PAD and 
Diabetic PAD in response to a thigh cuff stimulus. 
Figure 2-16 shows that the healthy subject has a faster reaction to the thigh cuff as well as 
a greater magnitude response than the patients with affected vasculature. This is analogous with 
the results of our 3 subject pilot study.  This further validates that the patterns we found, and 
enables us to explain the outcome using vascular models.   
 
2.6 Forty-subject pilots study  
In addition to the case studies, I completed a forty-subject clinical pilot study in the Division of 
Vascular Surgery at the New York-Presbyterian Hospital–Columbia (NYP). The pilot study 
included three cohorts: 20 healthy subjects, 10 diabetic PAD patients, and 10 non-diabetic 
diabetic PAD patients. The goals of the study were to identify parameters that show: (1) VOTI 
could effectively diagnose PAD, (2) VOTI can diagnose PAD within the diabetic population, 
which is plagued by false negative readings using the current diagnostic methods due to calcified 
arteries and (3) VOTI can identify the severity of arterial disease within the patients. 
2.6.1 Study population 
The physicians assigned the patients in one of the three cohorts based on a combination of the 
patients’ ABI readings, segmental ultrasound waveforms, physical symptoms and medical 
history. The patients recruited were 75% male and 25% female, with a mean age of 67.5 ± 11.5 
years.  Of the patients recruited 10% were current smokers, and 20% had been smokers in the 
past, but were non-smokers at the time of recruitment.  The ethnic make up of the patients was 







the subjects recruited none were smokers or had smoked habitually in the past. The healthy 
subjects were 80% male and 20% female, with a mean age of 35.6 ± 10.0 years.  Of the subjects 
recruited none were smokers or had smoked habitually in the past. The ethnic make up was 5% 
Hispanic, 60% Non-Hispanic White, 5% African American, and 30% Asian American.  
2.6.2 Statistical methods 
The features extracted from the images were analyzed relative to a baseline (percent changes). 
The data is presented in the form of mean and standard deviations unless otherwise stated. The 
data was stratified into healthy and affected vasculature for most of the analysis.  However, the 
affected vasculature was further stratified into non-diabetic PAD and diabetic PAD patients to 
determine the effect of diabetic co-morbidities on the results.  
To quantify VOTI’s ability to diagnose PAD, comparisons between groups were made 
using a one-way analysis of variance (ANOVA).  ANOVA however only tests the global 
hypothesis that all the samples were drawn from a single population. To identify which cohorts 
had statistically significant differences, we applied a multiple-comparison procedure called the 
Holm t-test. The Holm test is a sequentially rejective procedure because it applies an 
accept/reject criterion to a set of ordered null hypotheses based on their P value starting with the 
smallest and proceeding until it fails to reject the null hypothesis.   
To compute the Holm t test, the P-values are calculated using a traditional student’s t-test 
for each k groups.  Then we order these k P-values from smallest to largest.  The smallest is then 
compared to αj = αT /(k-j+1), where j is the group number.  With αT = 0.05 (95% confidence 
interval), and our three subject cohorts (k = 3), we obtain α1 = 0.0167, α2 = 0.025, α3 = 0.05. All 







addition, receiver operating characteristic (ROC) curves were then created for variables found to 
be statistically significant in order to calculate the sensitivity and specificity of the VOTI system 
for diagnosing PAD.  
To identify VOTI’s ability to assess the severity of PAD within the patients, the 
distributions of the data were analyzed using boxplots and Quantile-Quantile (Q-Q) plots. The 
boxplots show a graphical represent of the minimum and maximum values as well as the 
quartiles of the data. This information allows us to visually analyze the range, shape and 
skewness of the data. In addition, Q-Q plots are also used to compare the distributions of the 
healthy and affected vasculature patients.  If the quantiles of the data do not lie on a line of slope 
1, then you can deduce that there are differences between the distributions.  By plotting the Q-Q 
plot comparing the two affected vasculature cohorts, we can identify if VOTI system’s analysis 
is affected by diabetic co-morbidities, such as arterial calcification. 
2.6.3 ABI measurements 
The patients recruited underwent the traditional diagnostic procedures before undergoing the 
VOTI protocol.  The ABI readings were collected for the patients with affected vasculature (Fig. 
2-17). The PAD patient cohort had an average ABI of 0.64 ± 0.21 indicating moderate affected 
disease, while the diabetic PAD cohort had an average ABI of 0.95 ± 0.35, which would be 
misinterpreted as healthy vasculature. Using a student’s t-test, a statistically significant 
difference (P=0.05) is observed in the ABI readings despite both patient cohorts being previously 
diagnosed with arterial disease by the physician.  The difference is due to arterial calcifications, 
which render the arteries of incompressible and falsely elevate the ABI readings.  This implies 









Figure 2-17  This graph shows a comparison of the ABI measurements of the PAD cohort and the PAD with 
diabetes cohort.  We observe that the PAD cohort has an average of 0.64 ± 0.21 indicative of moderate arterial 
disease, while the diabetic PAD cohort has an average of 0.95 ± 0.35, which would be misinterpreted for healthy 
vasculature.  There is a statistically significant difference (P=0.05) between the two cohorts.  This suggests that the 
ABI is not ineffective in the diabetic patients due to their arterial calcifications causing falsely elevated 
measurements.  
 
2.6.4 Hemoglobin time trace 
Analyzing all 40 patients, we observe the same trends can be seen within the weighted average 
total hemoglobin traces. Fig. 2-18 shows, the average of the healthy, PAD and diabetic PAD 
subjects with their standard error bars. We observe that all three cohorts have the distinct five-
stages that are described in Section 2.2.  There appear to be significant differences between the 
peak intensity reached during both the 60mmHg and 120mmHg thigh cuff occlusions.  Fig. 2-18 
shows that the standard error bars for the healthy patient hemoglobin traces do not overlap with 
those of the patients with affected vasculature.  In addition, the hemoglobin time traces for the 
both PAD patient cohorts are very similar, implying that VOTI is independent of the arterial 








Figure 2-18  This figure shows the cohort signal average of the subjects recruited in the study along with positive 
and negative standard error bars. We observe that the healthy cohort average’s error bars do rarely overlap with the 
error bars of the affected patient cohorts. Furthermore the biggest different between the cohort occurs at the 
60mmHg occlusion peak. The healthy subjects have a faster and greater amplitude changes than the PAD groups, 
and there is only a slight difference between the PAD and the diabetic PAD group, showing that this VOTI imaging 
protocol is not affected by arterial compressibility. 
 
2.6.5 Diagnosis using 60mmHg peak 
The difference between the changes in [HbT] for healthy subjects and patients with PAD at the 
end of the 60mmHg occlusion is particularly pronounced.  To investigate this feature further, it 
was extracted from each patient and boxplots were created for the three cohorts (Fig. 2-19). The 
boxplots provide a visualization of the distribution of the 60mmHg occlusion peaks for the 
healthy, PAD and diabetic PAD subjects.   
The boxplots (Fig. 2-19) show the median of the healthy subjects is almost double that of 
the PAD and diabetic PAD subjects (7.5%, 3.8%, 4.5% respectively).  Furthermore, the cohorts 
with affected vasculature differ by less than 2% in their median change in percent hemoglobin 
concentration. The range of the healthy distribution is much greater than that of the PAD and 







factors such as lifestyle activities (e.g. fitness, diet, or smoking) or other medical conditions such 
as Raynaud’s phenomenon, which will be further stratified in larger clinical studies.  The largest 
value within the healthy subjects is an 18.27% change in hemoglobin, while the affected cohorts 
are less than half of that at less than 9% change. 
 
Figure 2-19  These boxplots represent the change in total hemoglobin concentration at the end of the 60mmHg 
occlusion for each of the three subject cohorts. The healthy distribution has a greater median than the affected 
cohorts. In addition, the affected cohorts have similar distributions despite the arterial calcifications.  Furthermore, 
the healthy population contains a larger range of values, possibly signifying that some of the subjects may have 
asymptotic circulatory problems. 
 
To quantify the 60mmHg peak’s ability to diagnose PAD, the parameter was extracted 
from the hemoglobin time traces for subject. Comparing the peak’s mean and standard deviations, 
we observe that the healthy cohort had a mean of 9.84 ± 5.44 (%), the PAD patient cohort had a 
mean of 4.41 ± 2.02 (%) and the diabetic PAD cohort had a mean of 4.78 ± 1.93 (%).  The mean 
and standard error bars of the three cohorts are shown in Fig. 2-20. 

















Figure 2-20  This graph shows a comparison of the maximum hemoglobin change during the 60mmHg thigh cuff 
occlusion between the three cohorts, along with their standard error bars.  There is a significant difference (P=0.006, 
P=0.006) between the healthy cohort and those with affected vasculature, while the difference between affected 
cohorts is not statistically significant (P=0.34). This suggests VOTI can discern between healthy and affected 
vasculature in the foot, without any hindrance from arterial incompressibility. 
 
A one-way ANOVA was applied to the data and a between-group P-value of 0.003 was 
obtained, which implies there is a statistical significant difference between the three subject 
cohorts. Using a student’s t-test, the P-values were obtained between the healthy and PAD 
cohorts, the healthy and the diabetic PAD cohort, and the PAD and diabetic PAD cohort 
(P=0.006, P=0.006, P=0.34).  Using the Holm t-test outlined in section 2.5.2, we observe that the 
healthy and PAD and healthy and diabetic PAD cohorts show a statistically significant difference 
(95% confidence interval) while the PAD and diabetic PAD do not show a statistical significance.  
This is expected, as VOTI is independent of arterial calcification and should not be affected by 








Figure 2-21  This figure shows a ROC curve created using the maximum hemoglobin concentration change during 
the 60mmHg thigh cuff occlusion to diagnose PAD. This feature is a good classifier of arterial disease with an 
AUC=0.81. The VOTI system shows a significant improvement over the traditional diagnostic tests, which rely on 
arterial compressibility. 
 
The 60mmHg peak was used as a diagnostic parameter for PAD and a receiver operating 
characteristic (ROC) curve was derived (Fig. 2-21). This single feature is a good classifier of 
arterial disease with an area under the ROC curve (AUC) of 0.81.  We can calculate the 
sensitivity (Se) and specificity (Sp) for the VOTI system using a 60mmHg Δ[HbT]% peak value 
cut off. If we designate all patients with Δ[HbT] < 6.1% as afflicted by PAD, we achieve a 
sensitivity of 0.85 and specificity of 0.73.  In this case the positive predictive value is 0.81 and 
the accuracy of the test equals 0.80.  
This is a great improvement compared to the ABI reading observed responses within the 
calcified patient population. If higher specificities are desired, the cutoff value can be lowered 
from 6.1% to 5.0%. Therefore, if we designate all patients with Δ[HbT] < 5.0% as afflicted by 







value is 0.88 and the accuracy of the test equals 0.77. Table 4 summarizes the ranges of 










Table 4  This table summarizes the results from the ROC curve analysis showing the possible sensitivity and 
specificity values for select Δ[HbT]% cutoff values. If a patient has a Δ[HbT]% value smaller than the listed cutoff, 
he/she is considered to be afflicted by PAD. Varying the cutoff values leads to different sensitivities and specificities 
as shown on the ROC curve (Fig. 9) and can be adjusted depending on the clinical need.  
 
2.6.6 Severity analysis using 60mmHg peak 
Next we asked if the VOTI system is capable of assessing the severity of the disease with the 
affected patient cohort. The first step in this analysis is to observe the full distribution of the 
60mmHg peaks from each cohort. This was accomplished by using a quantile-quantlie (Q-Q) 
plot. This analysis identifies if there are any outliers or skewed values as well as deduces if two 
cohorts likely come from the same population. The second step is to compare the values obtained 
to their respective ABI readings and compute the correlation coefficient between the two values.   
Δ[HbT] % cutoff Sensitivity  Specificity 
< 9.0 1.00 0.53 
< 7.4 0.90 0.67 
< 6.1 0.85 0.73 
< 5.0 0.70 0.87 
< 4.8 0.60 0.92 








Figure 2-22  (A) Q-Q plot comparing the Δ[HbT] distributions of the healthy subjects and the patients with affected 
vasculature.  It is observed that the healthy subjects have larger change in intensity than those with affected 
vasculature as well as a greater spread as one proceeds to the larger values.  This plot also indicates that there is a 
difference in the spread of the data most likely attributed to the varying health conditions of the healthy subject 
cohort. (B) Q-Q plot comparing the PAD subject cohort with the diabetic PAD subject cohort.  It is observed that the 
PAD subject distribution does not vary from the diabetic PAD subject cohort, indicating that the VOTI system is 
independent of the co-morbidities associated with diabetes. 
 
Q-Q plots were used to compare the three cohorts in the study (Fig. 2-22).  This plot is 
used to determine if two datasets come from the same population.  The quantiles of two 
distributions are plotted against each other and if the quantiles lie on a line with a slope of 1 then 







subject cohort with the PAD subject cohort and the diabetic PAD subject cohort respectively.  
We observe that the quantiles lie below the dashed line with the slope of 1.  This indicates that 
the healthy subjects have a higher valued distribution than the affected vasculature (i.e. the 
hemoglobin changes are greater for healthy subjects than subjects with PAD).  Furthermore, the 
distance between the points and the dashed line increase with the larger values, implying that the 
differences between the distributions increase as you move into the higher values (i.e. the 
differences between the largest hemoglobin changes in the healthy cohort and the largest 
hemoglobin changes in the affected cohort are much greater than the differences between 
smallest hemoglobin changes in the healthy cohort and the smallest hemoglobin changes in the 
affected cohort).   
The same analysis was done to compare the PAD subjects to the diabetic PAD subjects 
(Fig. 2-22C).  In this Q-Q plot, the points lay on line of slope 1.  This indicates that the two 
distributions have a very similar values and spread.  This further strengthens the hypothesis that 
VOTI imaging is independent of arterial calcifications. 
 The Q-Q plots show that the healthy cohort has a different distribution than the cohorts 
with affected vasculature and that affected vasculature cohorts have similar distributions.  
However, to quantify VOTI’s ability to assess PAD, the subjects’ 60mmHg peak values were 
compared against their respective ABI measurements (Fig. 2-23).  The 60mmHg peaks were 
plotted against their respective ABI values for the affected subjects.  For the PAD subjects, a 
linear trend is observed between the two parameters with an R2 = 0.84 (Fig. 2-23A). This implies 
that VOTI readings are directly proportional to the ABI measurements and therefore have the 








Figure 2-23  (A) This figure shows a strong linear relationship between the maximum change in hemoglobin 
concentration during the 60mmHg thigh cuff occlusion and the non-diabetic PAD patients’ ABI readings. This 
suggests that VOTI can differentiate between different severities of PAD similar to the current standard of care the 
ABI measurement. (B) This figure shows that there is no relationship between ABI measurement and maximum 
change in hemoglobin concentration within diabetic PAD patients. This is due to arterial calcification falsely 
elevating the ABI readings. VOTI does not suffer from arterial compressibility as shown by the equivalent Δ[HbT] 
distributions for the non-diabetic PAD and diabetic PAD cohorts in the prior Q-Q plot analysis. This suggests that 
VOTI should be able to identify severity within the diabetic PAD patients as well.  
 
 The ABI values for diabetic patients however are falsely elevated due to arterial 
calcifications.  As expected, when the same analysis was conducted for the diabetic PAD cohort 
there is no longer a linear relationship between the parameters with an R2 = 0.11 (Fig. 2-23B). 
This is consistent with the discrepancies found in the PAD and diabetic PAD patient ABI values 
(Fig. 2-17).  However, we determined that this discrepancy was not observed using the VOTI 
system as shown in the Q-Q plot of Fig. 2-23C. Therefore, it is possible to deduce that since the 
VOTI readings correlate with the severity of the disease even when ABI does not.  VOTI’s 
ability to diagnose and assess PAD independently of arterial calcification fulfills an unmet 








Figure 2-24  Comparing the VOTI readings with their corresponding PVR waveforms. 
 
We compared the VOTI results with those of the subject’s foot PVR pulses.  This allows 
us to compare a qualitative method to the quantitative values derived from VOTI system.  The 
technicians classified the waveform shapes as mild, moderate or severely diminished.  Within 
our affected patient cohorts there were 6 patients with mildly diminished waveforms, 6 patients 
with moderately diminished waveforms, and 8 patients with severely diminished waveforms. We 
took the Δ[HbT] values within each of the three degrees of severity of the disease.  The average 
Δ[HbT] for each severity is shown in Fig. 2-24 along with the 20 healthy subjects recruited.   
The healthy subject had a mean Δ[HbT] of 9.82 ± 5.71 (%), the mildly diminished 
waveforms had a mean of 5.98 ± 1.96 (%), the moderately diminished group had a mean of 4.1 ± 







decreased with the severity of the disease, this is expected as the resistance due to plaque and the 
lack of compliance from calcification decrease the amount of blood pooling.  All of the three 
severity levels (mild, moderate, and severe) were significantly different than the healthy subjects 
(P=0.04, P=0.003, P=0.0007). 
2.6.7 Spatial analysis 
In addition to amplitude changes, it is possible to look at spatial features, such as the percentage 
of volume within the foot that responds to the cuff stimulus, as diagnostic parameters. We 
defined, the average of the hemoglobin time trace for the healthy subjects shown in Fig. 2-18 as 
the ideal healthy response. Then calculated the correlation coefficients between the pixels inside 
each subject’s foot and this healthy ideal healthy response. The percentage of pixels with a 
correlation coefficient greater than 0.8 was then calculated each subject.  
 
Figure 2-25  This figure shows cross-sectional images of three case comparing the volume of pixels that correlate 
with the average healthy signal in white and the remaining pixels in black.  Fig. 2-25A shows a healthy subject, 
while Fig. 2-25B, and 2-25C show patients with affected vasculature. The healthy subject has a greater percentage 
of pixels that respond to the thigh cuff occlusion than those with affected vasculature.  
 
Fig. 2-25 shows examples of the spatial analysis with the correlating pixels in white and the non-
correlating pixels in black. The healthy subject has a greater percentage of volume correlating 
with the healthy signal than the subjects with affected vasculature.  This analysis could be used 







Fig. 2-26 shows the average percent volume of the foot that responds to the cuff inflation 
for the three cohorts. The healthy subjects have on average 11.24 ± 13.2 (%) of volume 
correlating with the healthy signal, while the PAD only cohort has 2.42 ± 3.37 (%) and the 
diabetic PAD cohort has 3.60 ± 3.80 (%).  Conducting a one-way ANOVA test, a P-value of 
0.047 was obtained. Then using a student t-test, P-values of 0.074 and 0.94 were calculated 
between the health subjects and the PAD subjects and the diabetic PAD subjects respectively. 
The high standard deviation in the healthy subjects weakened the statistical significance.  
However, with a larger enrollment number, we suspect that this will be a better diagnostic 
feature for PAD. 
 
 
Figure 2-26  This bar graph shows a comparison between the three cohorts for the percentage of volume that 
correlates with the healthy signal above a threshold of 0.8.  The error bars show the standard error for each of the 
three cohorts.  The standard deviations are higher in this feature, which limits the statistical significance (P=0.074 
P=0.094), however with a larger number of subjects it is expected that this variation will decrease and this feature 








2.6.8 Angiosome analysis 
Angiosome theory is a novel topic of great interest in vascular surgery [83-85, 87-104]. 
Angiosome theory states that a specific artery will contribute to the perfusion of the same region 
of the foot for all patients (e.g. the anterior tibial artery (ATA) is responsible for the blood flow 
into the dorsal surface of the foot). This implies that a lack of perfusion solely in dorsal surface 
of the foot would mean that there is a lesion along the ATA or one of its branches, such as the 
dorsalis pedis artery (DP). 
 
Figure 2-27  This figure shows an outline of the different angiosome regions that are captured within our cross-
sectional image of the foot.  On the dorsal surface, there is the dorsalis pedis angiosome (DPA). On the plantar 
surface there are the lateral plantar artery (LPA) and the medial plantar artery (MPA). 
!
Three angiosomes are captured within the mid-metatarsal, coronal cross-section: (1) the 
dorsalis pedis artery angiosome (DPA), (2) the medial plantar artery angiosome (MPA), and (3) 
lateral plantar artery angiosome (LPA).  The DPA is located at the dorsal surface of the foot, 
while the LPA and MPA are at the plantar surface (Fig. 2-27). To explore the spatial information 
within the VOTI image reconstructions, the images were segmented into the three angiosome 
regions and looked for pixels within each angiosome that experience changes greater than 10% 







at least one of the angiosomes affected as opposed to the healthy subjects, which often had good 
signal in all of the angiosomes. Fig. 2-28 shows three cases imaged using the VOTI system. 
 
Figure 2-28  This figure shows the signals from the pixels in the images that had the greatest amplitude drop during 
the thigh cuff occlusion within each angiosome. This analysis is shown for three cases from the A) healthy subject, 
B) PAD patient and C) Diabetic PAD patient cohorts.  We observed that in the healthy subject all three angiosome 
regions behave similarly to each other.  In the first PAD subject the MPA is doing significantly better than the other 
angiosomes of the foot.  In the second PAD subject all 3 waveforms are very diminished which could imply that the 
subject has a very proximal occlusion.  
!
In the healthy subject, the calculated signals were fairly consistent within the three 
angiosomes, both in magnitude, as well as shape (Fig. 2-28A). For the subjects with affected 
vasculature, there were often different responses within the angiosomes (Fig. 2-28B), or they had 







signal than the DPA and LPA. In addition, the LPA is slightly higher in amplitude than the DPA. 
This implies that the plantar surface of the foot is behaving better than the dorsal surface. In this 
situation, the physician would be advised to intervene on the dorsal surface through the ATA to 
better treat the patient. Alternatively in Fig. 2-28C, all three angiosomes have diminished signals, 
which may imply that the occlusion is more proximal in the leg.   
There is currently no gold standard or ground truth for assessing angiosome perfusion; 
hence full statistical analysis is difficult. In the future, perhaps animal studies or limiting the 
patient population to distal lower extremity disease only who will be imaged using digital 
subtraction angiography may help in verifying the accuracy of the VOTI system. 
2.6.9 Discussion 
VOTI is a non-invasive, non-ionizing, contrast-free imaging modality that uses harmless red and 
near-infrared light to measure changes in hemoglobin concentrations in tissue. This technology 
has been applied to image PAD in the foot. VOTI shows a statistically significant difference 
between the hemoglobin changes in healthy and affected vasculature in the foot.  There is more 
blood pooling in the foot during a one-minute venous occlusion in healthy patients relative to the 
PAD patient cohort (P=0.006) and the diabetic PAD cohort (P=0.006).  For large vessel disease, 
the plaque build-up increases the resistance, as well as reduces the compliance of the vessels.  
This leads to a reduction of blood flow into the foot causing the decrease in blood pooling.  In 
small-vessel disease, the same effect can be caused by arterial stenosis.  During the venous 
occlusions, the thigh cuff is inflated, occluding the veins at the thigh level stopping blood from 
leaving the leg while not affecting the arterial flow of blood to the foot.  This enables us to image 








VOTI provides multiple ways for physicians to identify arterial disease, directly from the 
raw data, from image cross-sections of the hemoglobin content and diagnostic parameters 
extracted from the images. The raw data shows the detector readings and how the detected light 
intensity changes during the course of the dynamic imaging protocol.  There was a drop in signal 
intensity upon application of a thigh cuff to induce venous occlusion.  The venous occlusion lead 
to blood pooling in the foot, the increase in hemoglobin within the foot caused a greater 
attenuation in the light, which recovered back to its original intensity upon release of the cuff.  
The magnitude of the intensity drop differs between healthy and affected vasculature and could 
serve as diagnostic parameters for the degree of occlusion.  In addition to the raw time traces, 
using models of light propagation in tissue, cross-sectional images of the hemoglobin content 
within the foot over time were derived, creating a movie of the blood volume dynamics in 
response to the thigh cuff occlusion.  These images can be used to localize regions of poor 
perfusion within the foot.  Angiosome analysis can further aid in foot examinations and help 
physicians in planning vascular interventions.  Furthermore, diagnostic parameters can be 
extracted from the reconstructions to form a decision boundary to help physicians diagnose and 
monitor PAD in the lower extremities.  For example, the maximum hemoglobin concentration 
from the 60mmHg thigh cuff occlusion was found to be a good classifier of arterial disease with 
an AUC of 0.81. Using a 60mm Hg peak of less than 6.1% as the decision boundary, VOTI 
obtained a Se = 0.85 with Sp = 0.73. Using a lower cutoff Δ[HbT] < 5.0% yields a Sp = 0.87 but 
lowers Se to 0.7. Varying the cutoff Δ[HbT] enables the user to choose whether sensitivity or 
specificity is more important in their analysis. 
These results indicate that a physician would be able to effectively diagnose patients with 







working.  The diabetic patient cohort had significantly greater ABI measurements than the non-
diabetic PAD patients.  This is due to the falsely elevated blood pressure measurements caused 
by the arterial incompressibility.  Using the parameters extracted from VOTI the diabetic and 
non-diabetic PAD patients fall within the same range of values.  In addition, as shown in Fig. 2-
21, the parameters extracted from the VOTI images correlate fairly well (R2 = 0.84) with the ABI 
readings for the non-diabetic patients, but no correlation with the diabetic patients (R2 = 0.11).  
VOTI’s correlation with ABI readings implies that it is successful in not only a binary decision 
boundary, but can also identify the severity of the disease as well.  VOTI’s ability to non-
invasively provide localized physiological parameters can fulfill an unmet clinical need within 
the diabetic PAD patient population.   
VOTI provides a direct measurement of the foot perfusion, serving as an end-stage measure 
of the effects of the lesions or stenosis on the foot.  This technology can be used to non-
invasively diagnose as well as monitor patients with PAD independent of arterial calcification, 








3 Contact free imaging 
PAD patients often have ulcerations and gangrene making fiber-based imaging very difficult. 
After completing the 40 subject pilot study, it became apparent that in order for this to be a 
clinical imaging system the fibers should not have to be individually adjusted.  This is both time 
consuming, and introduces a large source of error within the imaging protocol as an air tissue 
boundary between the fiber and the foot will introduce artifacts into the results.  To overcome 
these limitations, I designed and constructed a contact free imaging system using collimated 
source fibers and a high-end electron multiplying charge coupled device camera intended for 
operation within the near infrared range.  The major novelties and improvements include (a) a 
contact-free imaging interface (b), three-dimensional imaging capabilities (c) camera-based 
detection.   
3.1  System design and implementation 
This system was designed with the purpose of imaging the perfusion response in the foot.  The 
imaging system is capable of providing 3D spatial information about the hemoglobin content in 
the foot at a fast enough frame rate to image hemoglobin changes.  Furthermore, it is contact-free, 
allowing for imaging of patients with open wounds and gangrene, which are troublesome for 
fiber based systems.   
The imager’s input unit is comprised of two laser diodes and an optical switch.  The laser 
diodes emit 660 and 860 nm lights onto the surface of the foot, through a 2x20 micro-electrical 
mechanical system (MEMS) optical switch. The optical switch takes the two laser diodes and 
distributes the outputs on to a maximum of 20 positions on the surface of the foot.  The detection 







45 degree silver coated mirror and an electron multiplying charge coupled device (EMCCD) 
camera.  The transmitted light reflects off of the silver mirror onto the camera, which then 
captures the frame and stores it for reconstruction. The synchronization of the optical switch and 
the camera frame capture is achieved through the LabVIEW user interface.  A block diagram of 
the imaging system can be found in Fig. 3-1. 
 
Figure 3-1  This figure outlines the interactions between the major components within the imaging system.  Two 
laser drivers regulate the intensity and temperature of the two wavelength of light used.  These two wavelengths are 
input into a 2x20 Optical Switch, which de-multiplexes the light among 20 collimated optical fibers. Using an 
RS232 serial port and LabVIEW user interface controls the optical switch, enabling it to distribute the light and 
alternate the two wavelengths at each location. The optical fibers then shine light on different locations within the 
surface of the foot.  The light is scattered and absorbed and the transmitted light is bounced of a 45 degree protected 
silver coated mirror into an EMCCD camera which stores an image of light transmitted from each source 









Figure 3-2  This image shows the system components for the contact free imaging system, the lid on the black box 
enclosure is lifted to give a view of the EMCCD camera and the 45 degree protected silver mirror.  The power 
supply on the far left provides +/- 12V to the backplane, which powers the laser drivers and wires that necessary 
connections between the laser drivers and the laser diodes so that the laser drivers can in tern regulate the intensity 
and temperature of the laser diodes.  The laser diodes are input into the 2x20 optical switch, which distributes the 
light among the collimated fiber ends.  The fibers illuminate the foot and the transmitted light reflects off the mirror 
into the camera. 
 
3.1.1 Input unit 
The input unit is comprised of two 350mW continuous-wave laser diodes at 660 and 860nm 
wavelengths (Intense Inc).  The 660nm +/- 5nm laser diode is 350mW with a 105µm core and a 
numerical aperture (NA) of 0.22.  The 860nm +/- 5nm laser diode is 350mW with a 60µm core 
and an NA of 0.15.  These wavelengths were chosen to maximize the separation between 
absorption and scattering [105].  The laser diodes have a built in thermoelectric control (TEC) 
unit and come in a high heat load fiber package (HHLF). These laser diodes are regulated in 
intensity and temperature by two Thorlabs OEM laser drivers. The drivers run in constant current 







via a 64-pin input/output jack, which in turn wires the inputs and outputs between the diodes and 
the drivers. In addition, the backplane also provides power to the laser drivers via two 12V 
switching power supplies. This power supplies are capable of providing 8A loads each, and are 
rigged to provide positive and negative 12V lines to the backplane.   
 
 
Figure 3-3  The MEMS 2x20 Optical Switch is responsible for de-multiplexing the light from the two wavelengths 
among 20 optical fibers that distribute the light upon the surface of the foot.  The switch is comprised of a 2x1 
optical switch attached in serial to a 1x20 optical switch.  The first switch selects which wavelength to use and the 
second is responsible for distributing that wavelength among the source fibers.  The switch is programmed to 
operate by shining both wavelengths through one fiber then continuing to the next fiber location. 
 
Now that the laser diodes are fully functional, the next step is to distribute the light onto 
the foot.  The two wavelengths are de-multiplexed unto 20 two-meter long, 62.5µm core and 







because of its low attenuation in the NIR (1-5 dB/km).  These patch cables begin and terminate 
with angled physical contact fiber optic connectors (FC/APC to FC/APC) to reduce back-
reflections at the fiber tip.  
A very fast microelectromechanical system (MEMS) 2x20 multimode optical switch 
distributes the two wavelengths onto 20 optical fibers. This switch is capable of switching at 5ms 
while maintaining a low insertion loss of < 1.0 dB and a cross talk of -60dB between the 
individual channels.  The switch operates as if it is 2x1 switch attached serially to a 1x20 switch.  
The 2x1 switch toggles between the 2 wavelengths and the 1x20 switch toggles between the 20 
different source fibers that illuminate the foot (Fig. 3-3). The switch is connected to the computer 
by an RS232 serial port and operated by LabVIEW software.  
The computer used does not contain any RS232 serial ports, so a USB to serial port 
connector was used to create a virtual serial port by installing the appropriate drivers onto the 
computer.  The serial port commands are sent to the switch via a LabVIEW user interface, which 
alternates the wavelengths and position being illuminated onto the foot.  The switch operates by 
time multiplexing the two wavelengths upon a single location then proceeding to move onto the 
next location (i.e. Source1 Wavelength1, Source1 Wavelength2, Source2 Wavelength1, Source2 
Wavelength2, ...etc.).  The RS232 port has a maximum baud rate of 57600, it communicates with 
8 bits, including 1 stop bit. 
 An FC/APC fixed wavelength 780nm-aligned aspheric lens fiber collimators is attached 
to each of the 20 source fibers coming from the 2x20 optical switch.  Collimators are wavelength 







deciding which wavelength the collimator is aligned to. 780nm wavelength collimators were 
chosen to allow the minimum distortion for both wavelengths.  
The collimators increase the 660nm wavelength laser spot size, as the distance between 
the fiber and the foot increases, while the spot size of the 860nm laser decreases with distance.  
However, since the distance between the collimator and the foot is less than six inches this effect 
is negligible as both laser diodes give a spot size of approximately 3mm.  The other option would 
be to have two different collimators one aligned to 660nm and the other to the 860nm 
wavelengths, however this would decrease the number of source positions in half, since the same 
fiber could not be reused and it would be more expensive as those wavelength alignments are not 
standard issue.   
The input unit uses collimated fibers to allow the light to be illuminated at a fast rate and 
at multiple wavelengths without requiring fiber-contact with the foot.  This will help in 
translating the VOTI system into the clinic due to its expedited setup time for imaging.  
Furthermore, contact-free illumination expands its application from an early screening diagnostic 
to an imaging modality that is used for monitoring patients with open wounds and post surgical 
interventions 
 
3.1.2 Detection unit 
The detection unit is comprised of a 6in x 2in, protected silver coated mirror (Rainbow Optics) 
and an electron multiplying charge coupled device (EMCCD) camera.  The light from the 
collimated fibers is transmitted through the foot and then reflects off the 45 degree protected 







The light reflects off the mirror and onto a Princeton Instruments ProEM 512 x 512pixels, 
16 x 16µm pixel (8.2 x 8.2mm imaging area), back illuminated EMCCD camera.  This camera 
has a high dynamic range of 16bits (96dB), as well as, a fast acquisition rate (34fps without 
binning).  Furthermore, Princeton Instruments has a proprietary ‘eXcelon’ coating, which heavily 
reduces the effects of etaloning. In the thin back-illuminated sensors reflections between the 
nearly parallel front and back surfaces of the chips cause them to act as etalons. This behavior 
leads to unwanted fringes of constructive and destructive interference, which artificially 
modulate a spectrum.  This usually prevents back-illuminated sensors from being used in the 
NIR wavelengths.  However, back-illuminated sensors have much greater sensitivity and are 
ideal for low light applications.  In the ProEM camera the back surface is processed in a 
proprietary way that helps to break up the etalon effect. The combination of these approaches has 
resulted in a CCD, which is uniquely suited to low light NIR spectroscopy. The EMCCD camera 
connects to the computer via a Gigabit Ethernet (GigE) interface and is operated using a 
LabVIEW user interface.   
The camera is paired with a 14mm focal length wide-angle camera lens.  This camera 
lens gives a 115° angle of view with dramatic perspective when used with a full-frame digital 
camera or 35mm film camera and a 92.5º angle of view with APS-C sized cameras.  However 
the CCD camera chip has a small 8mm x 8mm CCD chip; we do not observe any fish eye effects 
and we get roughly a 60º viewing angle.  This allows wide enough view to capture the entire 
mirror, while minimizing the distance between the camera and the mirror.  This allows us to 
shrink the size of the machine. This allows for a 6-inch wide view from a distance of less than 15 







The camera is operated with an exposure time of 200ms, which was experimentally found 
to obtain sufficient light detection while maintaining a manageable frame rate.  Utilizing a silver 
mirror and a specialized camera, it is possible to create an effective contact-free detection unit of 
the imager.  This will decrease set-up time by not requiring the user to place the detection fibers 
around the foot and verify that there is no air-tissue gap between the fiber and foot.  Furthermore, 
it replaces a limited number of detection fibers with 512 x 512 CCD chip for greater spatial 
resolution.  The contact-free illumination expands VOTI’s capabilities from an early screening 
tool to an imaging modality that is used for monitoring patients with open wounds and post 
surgical interventions. 
 
3.1.3 Geometry extraction 
To obtain the 3D geometry of the foot, as well as the source detector positions, PhotoModeler 
Scanner is software is used.  This software is capable of extracting measurements and 3D models 
from photographs.  Multiple photographs are taken around the patients’ foot along with 
proprietary ‘RAD coded targets’ (Fig 3-4).  These targets are automatically located and marked 
in photographs using the PhotoModeler software. The locations of the RAD targets in the 
photographs provides the software with the position of the camera and the angle at which the 
pictures were taken.   
The PhotoModeler software then begins to create a point cloud along the location that it 
believes the foot is.  These point clouds are then used to create a mesh that outlines the surface of 
the foot.  There are many points in the image that can be used as references to scale the surface 
mesh to the approximate size of the foot.  Furthermore, we use a module that illuminates all the 







software to cross-reference the locations of the beams in each of the images and provide the 
source positions on the foot’s surface.  The source locations are then input as the boundary 
conditions of the image reconstruction algorithm. 
The PhotoModeler software allows for a fast method of collecting the foot surface in the 
clinic without disturbing the patients or adding significant time to the imaging protocol.  The 
PhotoModeler software then proceeds to generate a three-dimensional surface mesh of the foot. 
Using this information we can then use GID software to generate a 3D volume mesh, which can 
be input into the image reconstruction algorithm. 
 
Figure 3-4  Surface Mesh of Foot Generated using PhotoModeler Scanner Software.  Fig. 3-4A shows representative 
photographs taken at different angles encompassing the foot. Fig. 3-4B shows the PhotoModeler interface with the 
locations of the different camera positions used.  Fig. 3-4C shows the final surface mesh of the foot used in the 








3.1.4 User interface 
The system is currently operated through a LabVIEW graphical user interface.  This interface 
enables the user to select the number of source positions used, the number of wavelengths used, 
the exposure time of the camera, the amount of electron multiplying gain applied by the camera, 
as well as the number of frames to capture in the imaging protocol.  The user interface is shown 
in Fig. 3-5.  A screen shot of the LabVIEW code is shown in Fig. 3-6 and a block diagram of the 
code is shown in Fig. 3-7. 
Fig. 3-7 outlines the major steps taken by the LabVIEW code to interface between the 
input and the detection modules of the imaging system.  Upon taking in the user inputs, the 
LabVIEW interface synchronizes all the events so that the light illumination by the optical 
switch and the frame capture from the EMCCD camera occur simultaneously.  The exposure 
time, pixels used and the amount of binning are all sent to the camera from the LabVIEW user 
interface via the GigE port.  For the acquisitions, a region of interest within the CCD array was 
used.  The pixels used in the X direction were 87 to 386 and in Y from 219 to 299.  This region 
of interest minimized the number of pixels needed, so that pixels were just enough to cover the 
slit size. This in turn increases the frame rate, allowing for greater temporal resolution of the 
hemodynamic responses.  
After all parameters are sent to the camera, the camera then switches to acquisition mode.  
A clean is performed to remove the residual charge in the pixel wells.  Simultaneously the 
remaining inputs (i.e. number of frames and number of sources) are used to calculate the number 
pictures the camera should take to capture the desired number of frames.  Upon completion of 
the clean, the LabVIEW code sends the command ‘ch1’ to set the current source position in the 







serial port converter was used.  Drivers were installed to create a virtual serial port to 
communicate with the switch.  The serial port is set to ‘COM4’ on the front panel of the 
LabVIEW diagram (Fig. 3-5).  The command ‘ch?’ asks for the current source location, if the 
optical switch sends back the correct location the code continues, else it resends the command to 
switch source position.   
 
 
Figure 3-5  LabVIEW user interface for the VOTI system. The interface allows the user to input the camera 
exposure time the number of frames to capture, the amount of gain on the camera and the number of sources to use 
in the imaging sequence, as well as the number of pixels in both the X and Y direction and the amount of binning to 








The MEMS optical switch is programmed so that the codes 1-20 shine the light on the 20 
different illumination positions for wavelength 1 and the codes 21-40 shine the light onto the 20 
different positions for wavelength 2.  Since the wavelengths are time multiplexed in time, we 
send the codes so that both wavelength shine on a certain position before the position is changed 
(i.e. channel 1, channel 21, channel 2, channel 22 ... are sent to the optical switch in order to 
alternate between the two wavelengths before switching the illumination position).  Once the 
position is set the code sends a 3.3V TTL pulse via a National Instruments USB DAQ to the 
camera.  This triggers the camera to capture a frame once the camera exposure time has been 
reached.  The camera then sends it to the computer via the GigE port.   
The LabVIEW code creates a TIFF file and stores the captured image inside it.  The code 
will loop through all the different source positions for the two wavelengths and append the 
captured images together in the same TIFF file.  The code then checks if the correct number of 
frames has been captured, if not it will restart from source1 wavelengths 1 and capture another 
round of images and append it onto the same TIFF file.  Once the inputted number of frames has 










Figure 3-6.  This is an image of the block diagram of the LabVIEW code.  This code is responsible for taking in inputs from the user interface in Fig. 3-5 and 










Figure 3-7  This is a flow diagram of the LabVIEW code that synchronizes the camera and acquisition with the light 








3.1.5 Patient interface 
The patient interface allows for up to 20 fibers to illuminate the two wavelengths of light on top 
of the foot. The light propagates through the foot and is reflected off a protected silver coated 
mirror onto an EMCCD camera.  The patient interface is comprised of two boxes, the detection 
enclosure, which contains the major components of the detection unit and the illuminating 
enclosure, which holds the optical fibers and the subjects’ feet.  
3.1.5.1 Detection enclosure 
The larger rectangle box serves as the foundation of the patient interface.  This box is 36in x 12in 
x 9in and is designed to hold the detection unit, attenuate any ambient light, and serve as a 
patient friendly measuring probe to accommodate the various foot sizes that arise in the clinic. 
The box houses the silver coated mirror and the EMCCD camera, which are set at fixed distances 
onto the base of the detection enclosure onto a large black solid aluminum breadboard (Thorlabs).  
Off the aluminum breadboard are four 9in guide rails, which form the foundation of the box. 
Between each of these rails is a solid sheet of black acrylic used as the sides of the box. In 
addition, the base contains four caster wheels to allow for mobility in the clinic. 
In addition, to housing the detection unit, the detection enclosure is designed to keep 
ambient light out and to attenuate any stray reflections that may arise. It is imperative that there 
be no stray light seeping into the box during imaging, because the transmitted light intensities are 
very low and would be lost due to restrictions in the dynamic range. To mitigate the effects of 







reflective.  Furthermore, all black acrylic sheet used were covered with an attenuating black felt 
material to further reduce any ambient light. 
 
 
Figure 3-8 SolidWorks CAD Drawing of the measuring probe, the detection enclosure on the bottom contains the 
camera and a 45-degree silver coated mirror. The smaller box on top holds the optical fibers and can be elevated up 
and down via the two guide rails so as to allow for taking pictures of the foot.  The interface is set on four casters to 
allow for mobility within the clinical setting.  
 
The top piece of the detection enclosure is a 34in x 12in sheet of black acrylic that covers 
the entire top of the aluminum breadboard.  This top piece contains a 2in x 6in slit to allow light 
that has transmitted through the foot to pass onto the mirror.  This slit can be a major source of 
light leakage; so two sliding acrylic pieces with foam ends are used to prevent light from leaking 







directions to cover any portion of the slit that is not used to further reduce light entering into the 
box. A 3D computer-aided design (CAD) drawing of the measurement enclosure, which was 
completed using SolidWorks is shown in Fig. 3-8.  
 
3.1.5.2 Illumination enclosure 
On top of detection enclosure rests the illumination enclosure, which contains the collimated 
fibers.  This illumination enclosure is designed to house the subject’s foot, hold the optical fibers 
that will input the light and prevent ambient light from entering into the system. The collimated 
fibers are screwed into the top face of the illumination enclosure.  The top face contains 20 holes 
in a 3 line staggered pattern (Fig. 3-9).  The illumination enclosure is capable of gliding 
vertically along two 20inch-guide rails, which allows the user to take photographs of the foot 
without having the patients move their feet. These photographs are used in combination with the 
PhotoModeler scanning software to obtaining the geometry of the foot.  In addition, it also 
allows for aligning the foot with the slit in the larger rectangular box.   
 The illumination enclosure encompasses the foot and holds the fibers in place during the 
imaging protocol.  The side of the box facing the patient has a dense foam sponge interface that 
press down on the foot after insertion to prevent ambient light from entering the box. The patient 
places his/her foot through onto the strip of the larger box and then the foam material is lowered 
onto the foot to prevent any stray light from entering.  The light then is shown from fibers on top 
of the illumination enclosure, propagates through the foot and through the slit into the detection 







camera.  The remainder of the system components are placed a small pushcart.  The MiniCart 
(Anthro) was chosen to house the PC system, monitor, input unit and the optical switch.  Its 
minimalist design makes it ideal for moving about the hospital. 
 
 
Figure 3-9  The above shows the source fiber configuration on top of the small black box. The collimator lens 
system are threaded on top so they screws into the holes shown above, which are laser cut on top of the small black 
box.  The peak of illuminated beam is at the center of the holes. The configuration has three rows of fibers, which 
are staggered to fit multiple fiber locations within the small 2inch by 6inch slit in the larger box. 
 
3.1.5.3 Patient-User Interface. 
The current setup is designed to allow the physician to have direct contact with the patient while 
performing the imaging analysis. The patient is seated during the procedure and while the 
physician is standing on the opposite side. The patient and the physician are facing each other, 
allowing the physician to constantly monitor the patient while imaging as well as provide a 








Figure 3-10  Picture of the built completed the black-box interface is much more atheistically pleasing than the right 
probes with screw guided fibers alignment.  It is friendly looking and requires significantly less maintenance than 
the fiber-based imaging. 
 
3.2 System characterization 
To verify the system was functioning correctly, I employed two tests to verify input and 
detection unit function. Light was shone through a rectangular phantom and the CCD camera 
recorded the output.  The phantom was 17.15 cm x 6.9 cm x 4 cm rectangular box filled with 
Intralipid® (Baxter 20% Fat emulsion) and black ink to make a solution with a background 
medium absorption of !! = 0.15!cm!! and !! = 10!cm!! at 850 nm.   
The first test was used to verify that the detection unit was correctly receiving the amount 
of light that was being shone by the input unit.  Light was shone through the intralipid phantom 
at different locations and the detected light intensity was recorded.  We increased the laser diode 







transmitted light at the different laser power intensities and plotted them against each other.  This 
was completed for each source positions and the average of the their detected intensities was 
taken.  We observe a linear trend between the source power and the detected intensity suggesting 
that the system is correctly detecting the light transmitted through the phantom (Fig. 3-11). 
 
Figure 3-11 Illuminated and Detected Intensity vs. Current Increase into Laser Driver. 
 
 Next we tested the linear drift of the system after being turned on for an elongated period 
of time.  The system detected light intensity captured during a 20-minute source illumination on 
the surface of the phantom.  We averaged the different source positions together and plotted 
them against the source power (Fig. 3-12).  We observed that the signal did not vary much 
through out the 20-minute interval (~3% change). Adding more cooling fans to the laser diodes, 
will help stabilize their temperature, which can reduce this drop in intensity. 





































Figure 3-12 Detected and Illuminated Intensity over Time 
 
3.3 Image reconstruction and the measurement operator 
The image reconstruction algorithm used for this contact-free VOTI system is similar to the one 
outlined in section 2.3.  The key difference stems from its contact-free design.  Unlike the fiber-
based VOTI system this CCD camera based VOTI does not make physical contact with the foot.  
A measurement operator is used to map light propagation from the object’s surface to the CCD 
chip.  Based on light propagation theory, the measurements of a contact-free imaging system 
with generalized optical components can be obtained from a linear transformation of the light 
intensity distribution on the surface of the imaging object.  
The measurement operator Q provides a mapping from a spatial distribution of emitted 
light ψ(r, s) on the tissue surface onto a measurable quantity on each pixel in a CCD image.  
Assuming that all the photons collected by the lens opening are deposited onto the corresponding 
CCD image area without any loss, the total radiant power dP !  leaving the surface element dA 




























and passing through the solid angle dΩ subtended by the lens opening at the dA is equivalent to 
the total radiant flux z incident on the differential area dA! on the CCD detection plane, given by 




where z(!!)  is the measurable quantity being compared to the prediction during the 
reconstruction process. Rewriting z(!!) in Eq. (26) as a function of fluence ϕ !  yields the ray 
transfer operator Q in a matrix-vector form as follows 
 z !! =
dA
dA!





π (! ⋅ !)dΩ!
!
!! !
= Q !, ! ϕ !  (27) 
where the operator Q(!) takes all into account such as the area ratio dA/dA!, position !, and the 
solid angle dΩ. 
 
3.4 Numerical analysis 
To test the experimental setup of the imaging system, we created a rectangular numerical 
phantom geometry with a cylindrical inclusion that changes position.  This rectangular phantom 
was 17.15 cm x 6.9 cm x 4 cm with a background medium absorption of !! = 0.15!cm!! and 
!! = 10!cm!! at 850 nm (Fig. 3-13).  Within the background medium we included a cylindrical 
rod inclusion. The inclusion had a radius of 0.5 cm and a !! = 0.3!cm!! and !! = 10!cm!! at 
850nm.  We ran the simulation with the cylinder inclusion translated vertically to check the 







box directly at the bottom and then translated vertically 2cm from the bottom and then 4cm from 
the bottom.   
  
Figure 3-13.  This is a schematic of the phantom experiment setup.  A cylindrical inclusion was placed at varying 
heights inside a rectangular box with length L = 17.15cm, width W = 6.9cm and height H = 4cm.  Twenty sources 
were illuminated from the top of the phantom and 5000+ detectors representing the elements in the CCD array 
picked up the transmitted light intensities.  Next to it is the 3D mesh of the setup. 
 
 The simulation was run using 20 sources and 6000 pixels as detectors; this is the same 
setup of the current imaging system.  The image reconstruction algorithm was tested with noise 
effects by making the SNR of the data 15 dB, representing typical noise levels encountered in 
previous optical tomography clinical experiments. 
 We were able to reconstruct the images for each of the phantoms and accurately identify 
the position of the cylindrical inclusion (Fig. 3-14).  To quantify the quality of the 
reconstructions we use the correlation factor ρ(!! , !! ), the deviation factor δ(!! , !! ), and the 
relative error ε(!! , !! ) 
 ρ !! , !! = !!
!,!!!!!! !!!,!!














σ !! , 
(29) 
 ε !! , !! = !!
!!!!!
!!!
!×!100!!!! . (30) 
Here ! and σ(!) are the mean and standard deviations of the absorption coefficient observed 
spatially.  We designate the exact and reconstructed distributions as !!  and !!  respectively.  
The correlation coefficient indicates the degree of structural similarity between the exact and 
reconstructed images, while the deviation factor describes the discrepancy in the absolute values 
of exact and estimated quantities.  The relative error shows the percent difference between the 
exact and reconstructed image. The closer ρ(!! , !! ) gets to unity and the closer δ(!! , !! ) and 
ε !! , !!  get to zero, the better the reconstruction. 
 
Figure 3-14:  This figure shows results from a numerical simulation.  The reconstructions show the phantom with a 
highly absorbing inclusion at various heights (x = 0 cm, 2cm and 4cm).  The simulation shows that this experimental 









 Correlation Deviation Relative Error (%) 
X = 4cm 0.96 0.29 6.04 
X = 2cm 0.97 0.26 4.73 
X = 0cm 0.96 0.27 6.12 
Table 5:  Analysis of numerical phantom results at three different heights at the center of the box. 
 
The numerical results show that we can detect the location of the inclusion with high 
accuracy as the correlation is close to 1.  The deviation factor is also fairly low (0.26-0.29) 
indicating that there are only minor discrepancies in the absolute values of the reconstructed 
images.  Furthermore the relative error is fairly low ranging between 4-7%. This shows that 
theoretically this measurement setup is sufficient for reconstructing anatomical information 
within the foot. 
 
3.5 Phantom analysis 
Given the positive results from the numerical phantom we mimicked the setup using a real 
Intralipid phantom with an ink-filled straw inclusion.  The experiment was run using 20 sources 
and 6000 detectors.  The phantom medium had the same dimensions and was run on the same 
mesh that the numerical phantoms were computed on.  The phantom was 17.15 cm x 6.9 cm x 4 
cm rectangular box filled with Intralipid® (Baxter 20% Fat emulsion) and black India ink to 
make a solution with a background medium absorption of !! = 0.15!cm!! and !! = 10!cm!! 







locations in box.  The absorber was placed at the center of the box directly at the bottom and then 
translated vertically 2cm from the bottom and then 4cm from the bottom. The cylinder was filled 
with 1% india ink to give a !! = 1!cm!!.  
 
Figure 3-15. 3D Reconstruction of the absorption coefficient of liquid phantom with a cylindrical absorber at the top, 
middle and bottom center of the box. 
 
The data was reconstructed producing three-dimensional spatial maps of the absorption 
coefficient within the medium.  Fig. 3-15 shows the localization of the absorber at the top, 
bottom and center of the liquid phantom.  We observe that in all three depths, the reconstruction 
was capable of correctly identify the location of the cylindrical ink absorber.  The ink straw had a 
higher absorption coefficient than the background medium and applying a threshold to the image, 
the cylindrical shape could be easily discerned from the background.  This result shows that 







different heights.  This makes VOTI a feasible option for spatial analysis of major light absorbers 
such as blood vessels, and can help physicians in localizing the perfusion response within 
different areas of the foot. 
 
3.6 Human subject dynamic data 
Next the system’s ability to image hemodynamics in vivo was tested on a healthy subject. 
Images were acquired during a 60mmHg pressure cuff occlusion at the thigh. 
3.6.1 Raw data 
As expected, in general we observed a decrease in the light intensity signal during the pressure 
cuff, which leads to pooling of blood in the foot.  As described in early chapters the increase in 
hemoglobin causes an increase in light absorption during imaging.  Upon release we observe the 
blood signal return to baseline.  By taking a look at the signal intensity over time in select pixels 
we can observe the signal drop during the thigh cuff occlusion.  This gives a preliminary analysis 
of the patient’s vasculature, it is hypothesized that the magnitude as well as the rate at which the 
blood pools can be indicative of vascular disease.  
Fig. 3-16 shows an example of the data outputted during the imaging protocol.  The 
protocol consisted for three phases a baseline period (10 frames /~1.5 minutes), a 120mmHg 
thigh cuff occlusion (10 frames/~1.5 minutes) and a recovery period (10 frames/~1.5 minutes).  
For a single source illumination, we found that the amount of light penetrating in the tissue is 







amount of light penetration gradually decreased as the blood pooled in the foot.  Then upon 
release of the thigh cuff the signal returns back to baseline.   
 
Figure 3-16.  This image shows the raw data that is outputted from the imaging system during a thigh cuff occlusion 
for a single source illumination. It is observed that the amount of light penetrating in the tissue decreases gradually 
during the occlusion period as the blood pools in the foot.  Then upon release of the thigh cuff the signal returns 
back to baseline.  The time trace shows the average light intensity in the entire foot relative to the baseline period.  It 
is observed that the signal remains fairly constant then upon occlusion (frame 10) it begins to decline with blood 
pooling then returns back to baseline upon release (frame 20). 
 
In addition to the viewing the raw images, a time trace of the relative light intensity can 
be calculated by averaging the pixel intensities in the foot and dividing it by the average pixel 
intensity during the baseline period (Fig. 3-16). The signal remains fairly constant during 
baseline (Frames 1-10) then upon occlusion it begins to decline as the blood pools in the leg 







3.6.2 Total hemoglobin reconstructions 
The raw data was input into the image reconstruction algorithm to produce spatial maps of the 
hemoglobin concentration in the foot.  These image reconstructions are three-dimensional which 
allow us to view a slab of the foot instead of a 2D cross-section.  With this one can monitor a 
larger section of the foot as well as multiple viewing angles.  Fig. 3-17 shows a reconstruction of 
the foot with coronal slices at four different coronal plane/slices for a given time point.  This 
enables a more comprehensive assessment of the spatially distributed perfusion in the food.  
 
Figure 3-17.  Coronal Slices of a 3D hemoglobin foot reconstructions at different locations within the three-
dimensional image at a single point in time. 
 
Fig. 3-18 shows representative reconstructions of the blood pooling in the foot during the 
thigh cuff imaging protocol.  We observe that the blood pools in the leg during the pressure cuff 
occlusion and then recovers back to baseline upon release.  This is due to venous occlusion in the 
foot.  The blood pools in the leg as arteries supply blood to the foot while the occluded veins do 
not let it leave the leg.  This is analogous to what we saw in the raw data, the light intensity 







We hypothesize that we will be able to see difference in the perfusion response in the foot 
between healthy and affected vasculature just as we did with the fiber-based VOTI design.  This 
system should be able to diagnose PAD in the lower extremities similar the previous VOTI 
system outlined in Chapter 2 with the added benefit of three-dimensional imaging capabilities 
and a contact-free design. 
 
Figure 3-18.  Representative hemoglobin reconstructions during a pressure cuff occlusion around a healthy 
volunteer’s thigh.  The VOTI system’s 3D imaging capabilities allow for multiple views of the subject’s foot. 
 
Applying a threshold to the images, we can find the locations of the most hemoglobin 







vasculature within the foot.  A threshold was set at greater 25mM [HbO2] and applied to the foot 
reconstructions.  The pixels with hemoglobin concentrations above the threshold are shown in 
Fig. 3-19.  We observe that the pixel regions are grouped together suggesting that they 
correspond to physical structures.  The hemoglobin regions are also located in the foot periphery, 
which is consistent with the locations of the vasculature and muscles in the foot. 
 
Figure 3-19  Image reconstruction showing regions with the largest amount of hemoglobin concentration.  These 
regions are most likely to coincide with the vasculature within the foot. 
 
 The hemoglobin regions can now be used to obtain quantitative values to assess the 
perfusion response in the foot.  The average of the pixels within each of the four largest 
hemoglobin regions were calculated over the duration of the thigh cuff occlusion.  Fig. 3-20 
shows the four largest regions and their corresponding hemodynamic signal.  The regions exhibit 
a clear response to the thigh cuff as previously seen in the raw data and the cross-sectional 
images of the entire foot.  However by targeting the regions with the highest hemoglobin 







 In Fig. 3-20, the hemoglobin signals show a large increase (10-35%) in the amount of 
blood within the different regions during the pressure cuff occlusion.  This is analogous with 
what we observed in the 40 subject clinical study with the previous iteration of the VOTI system.  
Furthermore, the signals do not fully return to baseline after pressure cuff occlusion.  This is 
maybe be due to muscle tone.  The muscles may have been activated during the cuff stimulus 
and is using more blood, similar to the effects of stretching.   
 
Figure 3-20  Hemodynamics can be extracted from specific regions within the foot that show the greatest amount of 
blood pooling during thigh cuff occlusion.  The regions show an increase in hemoglobin concentration during cuff 
occlusion as predicted and a decrease upon release. 
 
 Overall the system is capable of providing three-dimensional spatial maps of the 







provide the ability to view cross-sectional images at different planes within the volume of the 
foot, as well as different cross-sectional angles (i.e. coronal, sagittal, axial).  Furthermore, the 
data can be analyzed to obtain regions of interest that can be used to extract hemoglobin content 
within different spatial areas of the foot.  Providing physicians with a more comprehensive 
method to assess the foot perfusion. 
 
3.7 Discussion 
In this chapter I described the design and implementation of a dynamic contact-free diffuse 
optical tomography imager for imaging PAD in the foot.  To achieve a contact-free imaging 
system both hardware and software had to be redesigned in their entirety. No fibers are use to get 
in contact with the patient. Second, instead of using individual silicon photodiodes as detectors, a 
highly sensitive CCD camera is use to detect transmitted light intensity. The contact-free aspect 
allows for imaging without manual fiber adjustment which can be time consuming and if not 
done correctly can introduce artifacts due to air-tissue boundaries. By utilizing a contact free 
design, the imaging system becomes more suitable for post-surgical monitoring, as those patients 
are more likely to suffer from open wounds. The contact-free detection allows for faster set-up 
times and easier extraction of the imaging geometry.  This allows for the technology to 
accommodate various foot shapes and sizes while not require the use of matching fluids. In 
addition, patients with severe cases of PAD often have ulcerations and gangrene making fiber 







The imager has a dynamic range of 86 dB with a frame rate of 4 Hz/source*wavelengths at a 
200ms exposure.  The system can accommodate up to 20 source positions and 2 wavelengths.  
This frame rate is fast enough to image the dynamic in blood volume while allowing for multiple 
source illuminations for image reconstruction.  Subjects were imaged during venous occlusion 
and the system was able to detect the blood volume changes in the raw images from the camera.  
The signal intensity diminished as the blood pooled in the legs and absorbed more of the light 
being transmitted.  Upon release of the thigh cuff the blood rushed out of the leg and more of the 
light was able to transmit through the foot returning the signal intensity back to baseline values.  
Furthermore, by taking the average intensity of the pixels in the images, it was possible to 








4 Conclusion and future directions 
This dissertation investigates VOTI’s ability to diagnose and monitor PAD within the lower 
extremities. I began by modifying an existing measuring probe, so that it was capable of 
accommodating the various foot shapes and sizes observed in the clinic.  Upon completing the 
measuring probe, we conducted a 40 patient pilot study to show that VOTI was capable of 
diagnosing PAD, and fill the gaps within the current diagnostic procedures for diabetic patients. 
The VOTI system was also able to determine the severity of the disease with similar accuracy to 
both the ABI and PVR measurements currently done.  Furthermore, we showed that using 
angiosome theory, VOTI might be able to guide physicians in how to approach surgical 
interventions.  
Learning from the clinical pilot study, we modified the measuring probe to have greater 
degrees of freedom, and to make a better fiber contact with the foot. The new measuring probe 
was also compatible with a 3D scanning software called PhotoModeler. Having 3D image 
reconstructions allowed us to view the changes in total hemoglobin concentration in all the 
imaging planes.  As the results of the imaging were promising, we built a dedicated contact-free 
imaging system, to better cope with patients with gangrene and ulcerations. This system was 
tested on tissue phantoms and a healthy subject.   
There are many potential application of VOTI within the vascular disease realm. In the 
future, we hope to see VOTI used by physicians to assess how much of the foot is well perfused.  







restrictions.  In future studies, variables such as age, ethnicity, smoking, hyperlipidemia and 
hypercholesterolemia should be controlled.  This will allow for a much stronger conclusion as to 
whether VOTI can effectively diagnose PAD.   
 In addition to the diagnosis of PAD, the VOTI system can be used in guiding physicians 
in post-surgical monitoring.  We hypothesize that VOTI will be capable of detecting failed 
intervention procedures earlier than the traditional diagnostic procedures. By monitoring the 
patients pre and post surgical intervention we can see the immediate efficiency of the procedure 
without having to wait for symptoms.  In addition, by monitoring over time the physician can 
check the foot perfusion to see if restenosis or graft thrombectomy has occurred.  In more severe 
cases we hypothesize that the VOTI system will be able to assess the perfusion of the entire foot 
and create a decision boundary for how much of the foot needs be amputated if necessary.  
Preserving as much tissue as possible is essential to help the patient remain ambulant.   
Another application for this technology is that it can be adapted for use intra-operatively. 
VOTI can be used to image in the operating room during several surgical interventions including 
angioplasty. stent placement, atherectomy, endarterectomy, thrombectomy and vascular bypass.  
It can be used to provide real-time information during surgery as to whether increased blood 
flow is observed in the foot.  This could save a lot of patient time, allowing the physician to 
further intervene if the perfusion is not improved. 
There are other vascular disorders that could be imaged using the VOTI system.  Venous 
diseases such as chronic venous insufficiency, deep vein thrombosis can be monitored using the 







content within the ankle or calf to give information on the levels of edema.  Other applications 
include imaging arteriovenous fistulas, which are formed during revascularization due to 
blockages, as well as for hemodialysis in the arm.  The VOTI system can also play a large role in 
wound healing applications.  The monitoring of arterial, venous and diabetic ulcers can be of 
great help to physicians.  The hemoglobin content surrounding the foot could aid in determining 
whether a wound is likely to heal.   
VOTI is a great asset to the current standard of care in medical diagnostics.  Its ability to 
non-invasively image hemoglobin concentrations makes it a useful tool for several applications.  
With more clinical studies and further emphasis on the design of the patient interface, VOTI will 








1 Sanada, H., Higashi, Y., Goto, C., Chayama, K., Yoshizumi, M., and Sueda, T.: ‘Vascular 
function in patients with lower extremity peripheral arterial disease: a comparison of 
functions in upper and lower extremities’, Atherosclerosis, 2005, 178, (1), pp. 179-185 
2 Hirsch, A.T., Criqui, M.H., Treat-Jacobson, D., Regensteiner, J.G., Creager, M.A., Olin, 
J.W., Krook, S.H., Hunninghake, D.B., Comerota, A.J., Walsh, M.E., McDermott, M.M., 
and Hiatt, W.R.: ‘Peripheral arterial disease detection, awareness, and treatment in primary 
care’, JAMA : the journal of the American Medical Association, 2001, 286, (11), pp. 1317-
1324 
3 Hiatt, W.R.: ‘Medical treatment of peripheral arterial disease and claudication’, The New 
England journal of medicine, 2001, 344, (21), pp. 1608-1621 
4 Kullo, I.J., Bailey, K.R., Kardia, S.L., Mosley, T.H., Jr., Boerwinkle, E., and Turner, S.T.: 
‘Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology 
Network of Arteriopathy (GENOA) study’, Vasc Med, 2003, 8, (4), pp. 237-242 
5 Diehm, C., Kareem, S., and Lawall, H.: ‘Epidemiology of peripheral arterial disease’, 
VASA. Zeitschrift fur Gefasskrankheiten, 2004, 33, (4), pp. 183-189 
6 Garcia, L.A.: ‘Epidemiology and pathophysiology of lower extremity peripheral arterial 
disease’, Journal of endovascular therapy : an official journal of the International Society of 
Endovascular Specialists, 2006, 13 Suppl 2, pp. II3-9 
7 Ix, J.H., and Criqui, M.H.: ‘Epidemiology and diagnosis of peripheral arterial disease in 
patients with chronic kidney disease’, Advances in chronic kidney disease, 2008, 15, (4), pp. 
378-383 
8 Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., and Fowkes, F.G.R.: 
‘Inter-society consensus for the management of peripheral arterial disease (TASC II)’, Eur J 
Vasc Endovasc, 2007, 33, pp. S5-S75 
9 Glasser, S.P.: ‘On arterial physiology, pathophysiology of vascular compliance, and 
cardiovascular disease’, Heart disease, 2000, 2, (5), pp. 375-379 
10 M. Al-Qaisi, D.M.N., D.H. King, S. Kaddoura and M. Hamady ‘Imaging of peripheral 
vascular disease ’, Reports in Medical Imaging 2009, 2 (1 ), pp. 25-34  
11 Krnic, A., Vucic, N., and Sucic, Z.: ‘Duplex scanning compared with intra-arterial 
angiography in diagnosing peripheral arterial disease: three analytical approaches’, VASA. 







12 Wikstrom, J., Holmberg, A., Johansson, L., Lofberg, A.M., Smedby, O., Karacagil, S., and 
Ahlstrom, H.: ‘Gadolinium-enhanced magnetic resonance angiography, digital subtraction 
angiography and duplex of the iliac arteries compared with intra-arterial pressure gradient 
measurements’, European journal of vascular and endovascular surgery : the official journal 
of the European Society for Vascular Surgery, 2000, 19, (5), pp. 516-523 
13 Pollak, A.W., Norton, P.T., and Kramer, C.M.: ‘Multimodality imaging of lower extremity 
peripheral arterial disease: current role and future directions’, Circulation. Cardiovascular 
imaging, 2012, 5, (6), pp. 797-807 
14 Hielscher, A.H., Bluestone, A.Y., Abdoulaev, G.S., Klose, A.D., Lasker, J., Stewart, M., 
Netz, U., and Beuthan, J.: ‘Near-infrared diffuse optical tomography’, Dis Markers, 2002, 
18, (5-6), pp. 313-337 
15 Zhao, H.J., Gao, F., Tanikawa, Y., Homma, K., Onodera, Y., and Yamada, Y.: ‘Anatomical 
and functional images of in vitro and in vivo tissues by NIR time-domain diffuse optical 
tomography’, Jsme Int J C-Mech Sy, 2002, 45, (4), pp. 1033-1039 
16 Pogue, B.W., Patterson, M.S., Jiang, H., and Paulsen, K.D.: ‘Initial Assessment of a Simple 
System for Frequency-Domain Diffuse Optical Tomography’, Physics in medicine and 
biology, 1995, 40, (10), pp. 1709-1729 
17 Ntziachristos, V., Hielscher, A.H., Yodh, A.G., and Chance, B.: ‘Diffuse optical 
tomography of highly heterogeneous media’, IEEE transactions on medical imaging, 2001, 
20, (6), pp. 470-478 
18 Mourant, J.R., Freyer, J.P., Hielscher, A.H., Eick, A.A., Shen, D., and Johnson, T.M.: 
‘Mechanisms of light scattering from biological cells relevant to noninvasive optical-tissue 
diagnostics’, Appl Opt, 1998, 37, (16), pp. 3586-3593 
19 Bluestone, A.Y., Stewart, M., Lei, B., Kass, I.S., Lasker, J., Abdoulaev, G.S., and Hielscher, 
A.H.: ‘Three-dimensional optical tomographic brain imaging in small animals, part 2: 
unilateral carotid occlusion’, J Biomed Opt, 2004, 9, (5), pp. 1063-1073 
20 Hielscher, A.H., Klose, A.D., Scheel, A.K., Moa-Anderson, B., Backhaus, M., Netz, U., and 
Beuthan, J.: ‘Sagittal laser optical tomography for imaging of rheumatoid finger joints’, 
Physics in medicine and biology, 2004, 49, (7), pp. 1147-1163 
21 Kang, Y., Lee, J., Kwon, K., and Choi, C.: ‘Application of novel dynamic optical imaging 
for evaluation of peripheral tissue perfusion’, International journal of cardiology, 2010, 145, 
(3), pp. e99-101 
22 Liebert, A., Wabnitz, H., Steinbrink, J., Moller, M., Macdonald, R., Rinneberg, H., 







based on optical monitoring of a dye bolus by time-resolved diffuse reflectance’, 
NeuroImage, 2005, 24, (2), pp. 426-435 
23 Montcel, B., Chabrier, R., and Poulet, P.: ‘Detection of cortical activation with time-
resolved diffuse optical methods’, Appl Opt, 2005, 44, (10), pp. 1942-1947 
24 Goff, D.A., Buckley, E.M., Durduran, T., Wang, J., and Licht, D.J.: ‘Noninvasive cerebral 
perfusion imaging in high-risk neonates’, Seminars in perinatology, 2010, 34, (1), pp. 46-56 
25 Mesquita, R.C., Durduran, T., Yu, G., Buckley, E.M., Kim, M.N., Zhou, C., Choe, R., Sunar, 
U., and Yodh, A.G.: ‘Direct measurement of tissue blood flow and metabolism with diffuse 
optics’, Philosophical transactions. Series A, Mathematical, physical, and engineering 
sciences, 2011, 369, (1955), pp. 4390-4406 
26 Flexman, M.L., Vlachos, F., Kim, H.K., Sirsi, S.R., Huang, J., Hernandez, S.L., Johung, 
T.B., Gander, J.W., Reichstein, A.R., Lampl, B.S., Wang, A., Borden, M.A., Yamashiro, 
D.J., Kandel, J.J., and Hielscher, A.H.: ‘Monitoring early tumor response to drug therapy 
with diffuse optical tomography’, J Biomed Opt, 2012, 17, (1), pp. 016014 
27 Lin, Z.J., Ren, M., Li, L., Liu, Y., Su, J., Yang, S.H., and Liu, H.: ‘Interleaved imaging of 
cerebral hemodynamics and blood flow index to monitor ischemic stroke and treatment in 
rat by volumetric diffuse optical tomography’, NeuroImage, 2014, 85 Pt 1, pp. 566-582 
28 Shah, N., Cerussi, A.E., Jakubowski, D., Hsiang, D., Butler, J., and Tromberg, B.J.: ‘Spatial 
variations in optical and physiological properties of healthy breast tissue’, J Biomed Opt, 
2004, 9, (3), pp. 534-540 
29 Gulsen, G., Birgul, O., Unlu, M.B., Shafiiha, R., and Nalcioglu, O.: ‘Combined diffuse 
optical tomography (DOT) and MRI system for cancer imaging in small animals’, 
Technology in cancer research & treatment, 2006, 5, (4), pp. 351-363 
30 Tromberg, B.J., Pogue, B.W., Paulsen, K.D., Yodh, A.G., Boas, D.A., and Cerussi, A.E.: 
‘Assessing the future of diffuse optical imaging technologies for breast cancer management’, 
Med Phys, 2008, 35, (6), pp. 2443-2451 
31 Carpenter, C.M., Rakow-Penner, R., Jiang, S., Pogue, B.W., Glover, G.H., and Paulsen, 
K.D.: ‘Monitoring of hemodynamic changes induced in the healthy breast through inspired 
gas stimuli with MR-guided diffuse optical imaging’, Med Phys, 2010, 37, (4), pp. 1638-
1646 
32 Puszka, A., Herve, L., Planat-Chretien, A., Koenig, A., Derouard, J., and Dinten, J.M.: 
‘Time-domain reflectance diffuse optical tomography with Mellin-Laplace transform for 
experimental detection and depth localization of a single absorbing inclusion’, Biomedical 







33 Ma, W., Zhang, W., Yi, X., Li, J., Wu, L., Wang, X., Zhang, L., Zhou, Z., Zhao, H., and 
Gao, F.: ‘Time-domain fluorescence-guided diffuse optical tomography based on the third-
order simplified harmonics approximation’, Appl Opt, 2012, 51, (36), pp. 8656-8668 
34 Marjono, A., Yano, A., Okawa, S., Gao, F., and Yamada, Y.: ‘Total light approach of time-
domain fluorescence diffuse optical tomography’, Optics express, 2008, 16, (19), pp. 15268-
15285 
35 Lam, S., Lesage, F., and Intes, X.: ‘Time Domain Fluorescent Diffuse Optical Tomography: 
analytical expressions’, Optics express, 2005, 13, (7), pp. 2263-2275 
36 Lambermont, B., D'Orio, V., Gerard, P., Kolh, P., Detry, O., and Marcelle, R.: ‘Time 
domain method to identify simultaneously parameters of the windkessel model applied to 
the pulmonary circulation’, Archives of physiology and biochemistry, 1998, 106, (3), pp. 
245-252 
37 Lam, S., Lesage, F., and Intes, X.: ‘Time domain fluorescent diffuse optical tomography’, P 
Soc Photo-Opt Ins, 2004, 5578, pp. 179-187 
38 Kumar, A.T., Raymond, S.B., Dunn, A.K., Bacskai, B.J., and Boas, D.A.: ‘A time domain 
fluorescence tomography system for small animal imaging’, IEEE transactions on medical 
imaging, 2008, 27, (8), pp. 1152-1163 
39 Pogue, B., Testorf, M., McBride, T., Osterberg, U., and Paulsen, K.: ‘Instrumentation and 
design of a frequency-domain diffuse optical tomography imager for breast cancer 
detection’, Optics express, 1997, 1, (13), pp. 391-403 
40 Chen, L.Y., Pan, M.C., and Pan, M.C.: ‘Implementation of edge-preserving regularization 
for frequency-domain diffuse optical tomography’, Appl Opt, 2012, 51, (1), pp. 43-54 
41 Culver, J.P., Choe, R., Holboke, M.J., Zubkov, L., Durduran, T., Slemp, A., Ntziachristos, 
V., Chance, B., and Yodh, A.G.: ‘Three-dimensional diffuse optical tomography in the 
parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous 
wave clinical system for breast imaging’, Med Phys, 2003, 30, (2), pp. 235-247 
42 Pogue, B.W., Patterson, M.S., Jiang, H., and Paulsen, K.D.: ‘Initial assessment of a simple 
system for frequency domain diffuse optical tomography’, Physics in medicine and biology, 
1995, 40, (10), pp. 1709-1729 
43 Ren, K., Abdoulaev, G.S., Bal, G., and Hielscher, A.H.: ‘Algorithm for solving the equation 
of radiative transfer in the frequency domain’, Optics letters, 2004, 29, (6), pp. 578-580 
44 Netz, U.J., Hielscher, A.H., Scheel, A.K., and Beuthan, J.: ‘Experimental results for 
propagation of diffuse photon-density waves up to 1 GHz in a tissue-like medium 







45 Netz, U.J., Scheel, A.K., Beuthan, J., and Hielscher, A.H.: ‘Development of a finger joint 
phantom for evaluation of frequency domain measurement systems’, Conference 
proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and 
Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, 2006, 1, 
pp. 1937-1940 
46 Netz, U.J., Beuthan, J., and Hielscher, A.H.: ‘Multipixel system for gigahertz frequency-
domain optical imaging of finger joints’, The Review of scientific instruments, 2008, 79, (3), 
pp. 034301 
47 Schmitz, C.H., Graber, H.L., Luo, H., Arif, I., Hira, J., Pei, Y., Bluestone, A., Zhong, S., 
Andronica, R., Soller, I., Ramirez, N., Barbour, S.L., and Barbour, R.L.: ‘Instrumentation 
and calibration protocol for imaging dynamic features in dense-scattering media by optical 
tomography’, Appl Opt, 2000, 39, (34), pp. 6466-6486 
48 Lasker, J.M., Masciotti, J.M., Schoenecker, M., Schmitz, C.H., and Hielscher, A.H.: 
‘Digital-signal-processor-based dynamic imaging system for optical tomography’, The 
Review of scientific instruments, 2007, 78, (8), pp. 083706 
49 Flexman, M.L., Khalil, M.A., Al Abdi, R., Kim, H.K., Fong, C.J., Desperito, E., Hershman, 
D.L., Barbour, R.L., and Hielscher, A.H.: ‘Digital optical tomography system for dynamic 
breast imaging’, J Biomed Opt, 2011, 16, (7), pp. 076014 
50 Lasker, J.M., Fong, C.J., Ginat, D.T., Dwyer, E., and Hielscher, A.H.: ‘Dynamic optical 
imaging of vascular and metabolic reactivity in rheumatoid joints’, J Biomed Opt, 2007, 12, 
(5), pp. 052001 
51 Schweiger, M., and Arridge, S.R.: ‘Comparison of two- and three-dimensional 
reconstruction methods in optical tomography’, Applied optics, 1998, 37, (31), pp. 7419-
7428 
52 Hielscher, A.H., Klose, A.D., and Hanson, K.M.: ‘Gradient-based iterative image 
reconstruction scheme for time-resolved optical tomography’, IEEE transactions on medical 
imaging, 1999, 18, (3), pp. 262-271 
53 Klose, A.D., and Hielscher, A.H.: ‘Iterative reconstruction scheme for optical tomography 
based on the equation of radiative transfer’, Med Phys, 1999, 26, (8), pp. 1698-1707 
54 Flexman, M.L., Li, Y., Bur, A.M., Fong, C.J., Masciotti, J.M., Al Abdi, R., Barbour, R.L., 
and Hielscher, A.H.: ‘The design and characterization of a digital optical breast cancer 
imaging system’, Conference proceedings : ... Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology 







55 Siegel, A., Marota, J.J., and Boas, D.: ‘Design and evaluation of a continuous-wave diffuse 
optical tomography system’, Optics express, 1999, 4, (8), pp. 287-298 
56 Patachia, M.: ‘A simple continuous-wave diffuse optical tomography system for parametric 
investigation of different tissue phantoms’, J Optoelectron Adv M, 2013, 15, (3-4), pp. 155-
163 
57 Zhang, Q., Yin, L., Tan, Y., Yuan, Z., and Jiang, H.: ‘Quantitative bioluminescence 
tomography guided by diffuse optical tomography’, Optics express, 2008, 16, (3), pp. 1481-
1486 
58 Corlu, A., Choe, R., Durduran, T., Rosen, M.A., Schweiger, M., Arridge, S.R., Schnall, 
M.D., and Yodh, A.G.: ‘Three-dimensional in vivo fluorescence diffuse optical tomography 
of breast cancer in humans’, Optics express, 2007, 15, (11), pp. 6696-6716 
59 Wolf, U., Wolf, M., Choi, J.H., Levi, M., Choudhury, D., Hull, S., Coussirat, D., Paunescu, 
L.A., Safonova, L.P., Michalos, A., Mantulin, W.W., and Gratton, E.: ‘Localized 
irregularities in hemoglobin flow and oxygenation in calf muscle in patients with peripheral 
vascular disease detected with near-infrared spectrophotometry’, Journal of Vascular 
Surgery, 2003, 37, (5), pp. 1017-1026 
60 Casavola, C., Paunescu, L.A., Fantini, S., and Gratton, E.: ‘Blood flow and oxygen 
consumption with near-infrared spectroscopy and venous occlusion: spatial maps and the 
effect of time and pressure of inflation’, J Biomed Opt, 2000, 5, (3), pp. 269-276 
61 Milan, A., Freato, F., Vanzo, V., Camporese, G., Baraldi, M., Chiandetti, L., and Zaramella, 
P.: ‘Near-infrared spectroscopy measure of limb peripheral perfusion in neonatal arterial 
thromboembolic disease’, Minerva pediatrica, 2012, 64, (6), pp. 633-639 
62 Manfredini, F., Malagoni, A.M., Mandini, S., Felisatti, M., Mascoli, F., Basaglia, N., 
Manfredini, R., Mikhailidis, D.P., and Zamboni, P.: ‘Near-infrared spectroscopy assessment 
following exercise training in patients with intermittent claudication and in untrained 
healthy participants’, Vascular and endovascular surgery, 2012, 46, (4), pp. 315-324 
63 Mohler, E.R., 3rd, Lech, G., Supple, G.E., Wang, H., and Chance, B.: ‘Impaired exercise-
induced blood volume in type 2 diabetes with or without peripheral arterial disease 
measured by continuous-wave near-infrared spectroscopy’, Diabetes care, 2006, 29, (8), pp. 
1856-1859 
64 Kooijman, H.M., Hopman, M.T., Colier, W.N., van der Vliet, J.A., and Oeseburg, B.: ‘Near 
infrared spectroscopy for noninvasive assessment of claudication’, The Journal of surgical 
research, 1997, 72, (1), pp. 1-7 
65 Papazoglou, E.S., Weingarten, M.S., Zubkov, L., Zhu, L., Tyagi, S., and Pourezaei, K.: 







of patients with diabetes’, Biomedical instrumentation & technology / Association for the 
Advancement of Medical Instrumentation, 2007, 41, (1), pp. 83-87 
66 Perry, D., Bharara, M., Armstrong, D.G., and Mills, J.: ‘Intraoperative fluorescence vascular 
angiography: during tibial bypass’, Journal of diabetes science and technology, 2012, 6, (1), 
pp. 204-208 
67 Masciotti, J.M., Lasker, J.M., and Hielscher, A.H.: ‘Digital lock-in algorithm for biomedical 
spectroscopy and imaging instruments with multiple modulated sources’, Conference 
proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and 
Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, 2006, 1, 
pp. 3198-3201 
68 Ahmed, N., Nataraja.T, and Rao, K.R.: ‘Discrete Cosine Transform’, Ieee T Comput, 1974, 
C 23, (1), pp. 90-93 
69 Kim, H.K., Flexman, M., Yamashiro, D.J., Kandel, J.J., and Hielscher, A.H.: ‘PDE-
constrained multispectral imaging of tissue chromophores with the equation of radiative 
transfer’, Biomedical optics express, 2010, 1, (3), pp. 812-824 
70 Pogue, B.W., Davis, S.C., Song, X., Brooksby, B.A., Dehghani, H., and Paulsen, K.D.: 
‘Image analysis methods for diffuse optical tomography’, J Biomed Opt, 2006, 11, (3), pp. 
33001 
71 Khalil, M.A., Kim, H.K., Kim, I.K., Flexman, M., Dayal, R., Shrikhande, G., and Hielscher, 
A.H.: ‘Dynamic diffuse optical tomography imaging of peripheral arterial disease’, 
Biomedical optics express, 2012, 3, (9), pp. 2288-2298 
72 Sugimachi, M., Shishido, T., Miyatake, K., and Sunagawa, K.: ‘A new model-based method 
of reconstructing central aortic pressure from peripheral arterial pressure’, The Japanese 
journal of physiology, 2001, 51, (2), pp. 217-222 
73 Rietzschel, E.R., Boeykens, E., De Buyzere, M.L., Duprez, D.A., and Clement, D.L.: ‘A 
comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial 
stiffness’, Hypertension, 2001, 37, (6), pp. E15-22 
74 Masuzawa, T., Fukui, Y., and Smith, N.T.: ‘Cardiovascular simulation using a multiple 
modeling method on a digital computer--simulation of interaction between the 
cardiovascular system and angiotensin II’, Journal of clinical monitoring, 1992, 8, (1), pp. 
50-58 
75 Kim, H.J., Vignon-Clementel, I.E., Coogan, J.S., Figueroa, C.A., Jansen, K.E., and Taylor, 
C.A.: ‘Patient-specific modeling of blood flow and pressure in human coronary arteries’, 







76 Ruel, J., and Lachance, G.: ‘Mathematical modeling and experimental testing of three 
bioreactor configurations based on windkessel models’, Heart international, 2010, 5, (1), pp. 
e1 
77 K, S., Dunn, A.K., Duong, T.Q., and Ress, D.: ‘Measurements and modeling of transient 
blood flow perturbations induced by brief somatosensory stimulation’, The open 
neuroimaging journal, 2011, 5, pp. 96-104 
78 Papaioannou, T.G., Mathioulakis, D.S., Nanas, J.N., Tsangaris, S.G., Stamatelopoulos, S.F., 
and Moulopoulos, S.D.: ‘Arterial compliance is a main variable determining the 
effectiveness of intra-aortic balloon counterpulsation: quantitative data from an in vitro 
study’, Medical engineering & physics, 2002, 24, (4), pp. 279-284 
79 Olufsen, M.S., Nadim, A., and Lipsitz, L.A.: ‘Dynamics of cerebral blood flow regulation 
explained using a lumped parameter model’, American journal of physiology. Regulatory, 
integrative and comparative physiology, 2002, 282, (2), pp. R611-622 
80 O'Rourke, M.F., Staessen, J.A., Vlachopoulos, C., Duprez, D., and Plante, G.E.: ‘Clinical 
applications of arterial stiffness; definitions and reference values’, American journal of 
hypertension, 2002, 15, (5), pp. 426-444 
81 Huppert, T.J., Allen, M.S., Diamond, S.G., and Boas, D.A.: ‘Estimating cerebral oxygen 
metabolism from fMRI with a dynamic multicompartment Windkessel model’, Human 
brain mapping, 2009, 30, (5), pp. 1548-1567 
82 Huberts, W., de Jonge, C., van der Linden, W.P., Inda, M.A., Tordoir, J.H., van de Vosse, 
F.N., and Bosboom, E.M.: ‘A sensitivity analysis of a personalized pulse wave propagation 
model for arteriovenous fistula surgery. Part A: Identification of most influential model 
parameters’, Medical engineering & physics, 2013, 35, (6), pp. 810-826 
83 Neville, R.F., Attinger, C.E., Bulan, E.J., Ducic, I., Thomassen, M., and Sidawy, A.N.: 
‘Revascularization of a specific angiosome for limb salvage: does the target artery matter?’, 
Annals of vascular surgery, 2009, 23, (3), pp. 367-373 
84 Varela, C., Acin, F., de Haro, J., Bleda, S., Esparza, L., and March, J.R.: ‘The role of foot 
collateral vessels on ulcer healing and limb salvage after successful endovascular and 
surgical distal procedures according to an angiosome model’, Vascular and endovascular 
surgery, 2010, 44, (8), pp. 654-660 
85 Iida, O., Soga, Y., Hirano, K., Kawasaki, D., Suzuki, K., Miyashita, Y., Terashi, H., and 
Uematsu, M.: ‘Long-term results of direct and indirect endovascular revascularization based 
on the angiosome concept in patients with critical limb ischemia presenting with isolated 
below-the-knee lesions’, Journal of vascular surgery : official publication, the Society for 
Vascular Surgery [and] International Society for Cardiovascular Surgery, North American 







86 Van Vo, T., Hammer, P.E., Hoimes, M.L., Nadgir, S., and Fantini, S.: ‘Mathematical model 
for the hemodynamic response to venous occlusion measured with near-infrared 
spectroscopy in the human forearm’, Ieee T Bio-Med Eng, 2007, 54, (4), pp. 573-584 
87 McGregor, A.D.: ‘The angiosome--an in vivo study by fluorescein angiography’, British 
journal of plastic surgery, 1992, 45, (3), pp. 219-221 
88 Taylor, G.I., and Palmer, J.H.: ‘'Angiosome theory'’, British journal of plastic surgery, 1992, 
45, (4), pp. 327-328 
89 Aydin, M.A., and Mavili, M.E.: ‘Examining microcirculation improves the angiosome 
theory in explaining the delay phenomenon in a rabbit model’, Journal of reconstructive 
microsurgery, 2003, 19, (3), pp. 187-194 
90 Suami, H., Taylor, G.I., and Pan, W.R.: ‘Angiosome territories of the nerves of the lower 
limbs’, Plastic and reconstructive surgery, 2003, 112, (7), pp. 1790-1798 
91 Bazan, H.A.: ‘Think of the angiosome concept when revascularizing the patient with critical 
limb ischemia’, Catheterization and cardiovascular interventions : official journal of the 
Society for Cardiac Angiography & Interventions, 2010, 75, (6), pp. 837 
92 Iida, O., Nanto, S., Uematsu, M., Ikeoka, K., Okamoto, S., Dohi, T., Fujita, M., Terashi, H., 
and Nagata, S.: ‘Importance of the angiosome concept for endovascular therapy in patients 
with critical limb ischemia’, Catheterization and cardiovascular interventions : official 
journal of the Society for Cardiac Angiography & Interventions, 2010, 75, (6), pp. 830-836 
93 Yin, Z.X., Peng, T.H., Ding, H.M., Bai, B., and Tang, M.L.: ‘Three-dimensional 
visualization of the cutaneous angiosome using angiography’, Clin Anat, 2012 
94 Azuma, N., Uchida, H., Kokubo, T., Koya, A., Akasaka, N., and Sasajima, T.: ‘Factors 
influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome 
important in selecting bypass target artery?’, European journal of vascular and endovascular 
surgery : the official journal of the European Society for Vascular Surgery, 2012, 43, (3), pp. 
322-328 
95 Azuma, N.: ‘Response to Commentary on 'Factors influencing wound healing of critical 
ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target 
artery?'’, European journal of vascular and endovascular surgery : the official journal of the 
European Society for Vascular Surgery, 2012, 44, (1), pp. 105 
96 Alexandrescu, V., Soderstrom, M., and Venermo, M.: ‘Angiosome theory: fact or fiction?’, 
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and 







97 Alexandrescu, V., and Hubermont, G.: ‘The challenging topic of diabetic foot 
revascularization: does the angiosome-guided angioplasty may improve outcome’, The 
Journal of cardiovascular surgery, 2012, 53, (1), pp. 3-12 
98 Taylor, G.I., Corlett, R.J., Dhar, S.C., and Ashton, M.W.: ‘The anatomical (angiosome) and 
clinical territories of cutaneous perforating arteries: development of the concept and 
designing safe flaps’, Plastic and reconstructive surgery, 2011, 127, (4), pp. 1447-1459 
99 Alexandrescu, V., Vincent, G., Azdad, K., Hubermont, G., Ledent, G., Ngongang, C., and 
Filimon, A.M.: ‘A reliable approach to diabetic neuroischemic foot wounds: below-the-knee 
angiosome-oriented angioplasty’, Journal of endovascular therapy : an official journal of the 
International Society of Endovascular Specialists, 2011, 18, (3), pp. 376-387 
100 Alexandrescu, V., Ngongang, C., Vincent, G., Ledent, G., and Hubermont, G.: ‘Deep calf 
veins arterialization for inferior limb preservation in diabetic patients with extended 
ischaemic wounds, unfit for direct arterial reconstruction: preliminary results according to 
an angiosome model of perfusion’, Cardiovascular revascularization medicine : including 
molecular interventions, 2011, 12, (1), pp. 10-19 
101 Alexandrescu, V., and Hubermont, G.: ‘Primary infragenicular angioplasty for diabetic 
neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the 
vascular interventionist?’, Diabetes, metabolic syndrome and obesity : targets and therapy, 
2011, 4, pp. 327-336 
102 Setacci, C., De Donato, G., Setacci, F., and Chisci, E.: ‘Ischemic foot: definition, etiology 
and angiosome concept’, The Journal of cardiovascular surgery, 2010, 51, (2), pp. 223-231 
103 Rozen, W.M., Ashton, M.W., Le Roux, C.M., Pan, W.R., and Corlett, R.J.: ‘The perforator 
angiosome: a new concept in the design of deep inferior epigastric artery perforator flaps for 
breast reconstruction’, Microsurgery, 2010, 30, (1), pp. 1-7 
104 Hong, M.K., Hong, M.K., and Taylor, G.I.: ‘Angiosome territories of the nerves of the 
upper limbs’, Plastic and reconstructive surgery, 2006, 118, (1), pp. 148-160 
105 Corlu, A., Durduran, T., Choe, R., Schweiger, M., Hillman, E.M., Arridge, S.R., and Yodh, 
A.G.: ‘Uniqueness and wavelength optimization in continuous-wave multispectral diffuse 










List of relevant publications 
Patent 
Hielscher A.H., Khalil M.A., Dayal R., Kim I., & Kim H.K. (2013). US Patent 20,130,289,394. 
Washington, DC: US 
 
Journal 
MA. Khalil, JW. Hoi, HK. Kim, and AH. Hielscher, “Dynamic contact-free continuous-wave 
diffuse optical tomography system for the detection of peripheral arterial disease within the foot” 
in prep 
 
MA. Khalil, HK. Kim, JW. Hoi, I. Kim, R. Dayal, G. Shrikhande, and AH. Hielscher, 
“Detection of Peripheral Arterial Disease Within the Foot Using Vascular Optical Tomographic 
Imaging” in prep 
 
MA. Khalil, HK. Kim, I. Kim, ML. Flexman, R. Dayal, G. Shrikhande, and AH. Hielscher, 
"Dynamic diffuse optical tomography imaging of peripheral arterial disease," Biomed. Opt. 
Express  3, 2288-2298 (2012). 
 
Flexman ML, Kim HK, Stoll R, Khalil MA, Fong CJ, Hielscher AH, “A wireless handheld 
probe with spectrally constrained evolution strategies for diffuse optical imaging of tissue,” Rev. 
Sci. Instrum. 83, 033108 (2012). 
 
Flexman ML, Khalil MA, Al Abdi R, Kim HK, Fong CJ, Desperito E, Hershman DL, Barbour 
RL, Hielscher AH, “Digital optical tomography system for dynamic breast imaging,” J Biomed 
Opt. 2011 Jul;16(7):076014. 
 
Abstracts and Proceedings 
MA. Khalil, HK Kim, JW. Hoi, I. Kim, R. Dayal, G. Shrikande, AH. Hielscher, "Imaging of 
vascular dynamics within the foot using dynamic diffuse optical tomography to diagnose 
peripheral arterial disease", in Optical Tomography and Spectroscopy of Tissue X, Bruce J. 
Tromberg; Arjun G. Yodh; Eva M. Sevick-Muraca, Editors, Proceedings of SPIE Vol. 8578 
(SPIE, Bellingham, WA 2013), 85781M (March 25, 2013). 
 
MA. Khalil, JW. Hoi, HK Kim, AH. Hielscher, "Dynamic contact-free continuous-wave diffuse 
optical tomography system for the detection of vascular dynamics within the foot", in Optical 
Tomography and Spectroscopy of Tissue X, Bruce J. Tromberg; Arjun G. Yodh; Eva M. Sevick-
Muraca, Editors, Proceedings of SPIE Vol. 8578 (SPIE, Bellingham, WA 2013), 85781H (March 








HK Kim, MA Khalil, J Gunther, LD Montejo ; AH. Hielscher, “A dynamic image 
reconstruction method with spatio-temporal constraints”, in Proc. SPIE 8581, Photons Plus 
Ultrasound: Imaging and Sensing 2013, 858131 (March 4, 2013); doi:10.1117/12.2003394. 
 
MA. Khalil, H. Kim, M. Barbiero, I. Kim, R. Dayal, G. Shrikhande, and A. Hielscher, 
“Detection of Poor Blood Circulation in the Lower Extremities Using Dynamic Diffuse Optical 
Tomography” in First IEEE Healthcare Technology Conference: Translational Engineering in 
Health & Medicine, Nov. 7-9, 2012, Methodist Hospital Research Institute, Houston, TX 
 
MA. Khalil, HK. Kim, ML. Flexman, I. Kim, R. Dayal, and AH. Hielscher, "Measurement of 
Vascular Response within the Foot Using Dynamic Diffuse Optical Tomography," in Biomedical 
Optics, OSA Technical Digest (Optical Society of America, 2012), paper BTu2A.4. 
 
MA. Khalil, HK. Kim, I Kim, R Dayal, AH. Hielscher, "Application of dynamic diffuse optical 
tomography in lower extremity vascular imaging," in Diffuse Optical Imaging III, edited by 
Andreas H. Hielscher, Paola Taroni, Politecnico di Milano, Proc. of SPIE-OSA Biomedical 
Optics, SPIE Vol. 8088, 8808-54(2011). 
 
MA. Khalil, HK. Kim, I Kim, R Dayal, AH. Hielscher, "Detecting lower extremity vascular 
dynamics in patients with peripheral artery disease using diffuse optical tomography," in Optical 
Tomography and Spectroscopy of Tissue IX, edited by Bruce J. Tromberg, Arjun G. Yodh, 
Mamoru Tamura, Eva M. Sevick-Muraca, Robert R. Alfano, Proc. SPIE 7896, 78962Z(2011). 
 
I.K. Kim, M.A. Khalil, H.K. Kim, A.H Hielscher, R. Dayal, “Optical Tomographic Imaging 
(OTI) for Peripheral Arterial Disease (PAD): Prototype Development, Novel Applications, and 
Prospects for Future Clinical Use,” American Heart Associate Meeting on Arteriosclerosis, 
Thrombosis and Vascular Biology (ATVB) 2011, Chicago, Il, Apr 28-30, 2011. 
 
ML. Flexman, MA. Khalil, CJ. Fong, RM. Al Abdi, RL. Barbour, B Reig, D Hershman, E 
Desperito, AH. Hielscher, "Optical tomographic imaging of the hemodynamic response to a 
breath hold in breast cancer patients," in Optical Tomography and Spectroscopy of Tissue IX, 
edited by Bruce J. Tromberg, Arjun G. Yodh, Mamoru Tamura, Eva M. Sevick-Muraca, Robert 
R. Alfano, Proc. SPIE 7896, 78962J(2011). 
 
MA. Khalil, ML. Flexman, J Youssef, R Aparajita, I Kim, R Dayal, AH. Hielscher, "Measuring 
peripheral vascular reactivity with diffusive optical imaging," from the 36th Annual NEBC, 








Appendix 1: VOTI Bill of Materials 
Item Qty Specification Manufacturer Vendor Unit Price Total Price 
DETECTION 






















Camera Lens 1 
Canon EF 
14mm f/2.8L II 
USM Lens 




















      
MEMS Optical 
Switch 












Thorlabs Inc Thorabs Inc $159.96 $3,199.20 
Laser Diodes 2 











Thorlabs Inc Thorlabs Inc $610.00 $1,220.00 




































PhotoModeler PhotoModeler $1,995.00 $1,995.00 
PATIENT 











Rods (9", 20") 




McMaster McMaster $12.64 $88.48 
Casters 4 Rubber Wheels McMaster McMaster $40.00 $160.00 











Cart 1 Mini Cart Anthro Corp Anthro Corp $595.77  
 
$595.77 
     
Total $70,401.60  
 
 
 
